Acute and delayed transplantation of olfactory ensheathing cells	1
Acute and delayed transplantation	1
olfactory ensheathing cells	38
partial recovery after complete transection of the spinal cord Rube ` n Lo ' pez-Vales , a Joaquim Fore 's , a , b Enrique Verdu ' , a , * and Xavier Navarroa aGroup of Neuroplasticity and Regeneration , Institute of Neuroscience and Department of Cell Biology , Physiology and Immunology , Universitat Auto ` noma de Barcelona , E-08193 Bellaterra , Spain bHand and Peripheral Nerve Unit , Hospital Clı ' nic i Provincial , Universitat de Barcelona , Barcelona , Spain The present study was undertaken to determine whether olfactory ensheathing cells -LRB- OECs -RRB- from the olfactory bulb were capable to promote axonal regeneration and functional recovery when transplanted either acutely or 1 week delayed into the T8 transected rat spinal cord	74
partial recovery after complete transection of the spinal cord Rube ` n Lo ' pez-Vales , a Joaquim Fore 's , a , b Enrique Verdu ' , a , *	74
partial recovery	74
complete transection of the spinal cord Rube ` n Lo ' pez-Vales , a Joaquim Fore 's , a , b Enrique Verdu ' , a , *	97
complete transection	97
the spinal cord Rube ` n Lo '	121
the spinal cord Rube	121
n Lo	143
pez-Vales , a Joaquim Fore 's , a , b Enrique Verdu ' , a	148
pez-Vales	148
a Joaquim Fore 's	158
a	175
b Enrique Verdu '	177
a	195
Xavier Navarroa aGroup of Neuroplasticity and Regeneration	203
Xavier Navarroa aGroup	203
Neuroplasticity and Regeneration	229
Institute of Neuroscience and Department of Cell Biology , Physiology and Immunology , Universitat Auto ` noma de Barcelona , E-08193 Bellaterra , Spain bHand and Peripheral Nerve Unit	263
Institute	263
Neuroscience and Department of Cell Biology , Physiology and Immunology , Universitat Auto ` noma de Barcelona , E-08193 Bellaterra , Spain bHand and Peripheral Nerve Unit	276
Neuroscience and Department	276
Cell Biology , Physiology and Immunology , Universitat Auto	307
Cell Biology , Physiology and Immunology	307
Cell	307
Biology , Physiology and Immunology	312
Universitat Auto	348
noma de Barcelona	365
E-08193 Bellaterra	384
Spain bHand	404
Peripheral Nerve Unit	420
Hospital Clı ' nic i Provincial , Universitat de Barcelona , Barcelona , Spain The present study was undertaken to determine whether olfactory ensheathing cells -LRB- OECs -RRB- from the olfactory bulb were capable to promote axonal regeneration and functional recovery when transplanted either acutely or 1 week delayed into the T8 transected rat spinal cord	443
Hospital Clı '	443
i Provincial , Universitat de Barcelona , Barcelona , Spain The present study was undertaken to determine whether olfactory ensheathing cells -LRB- OECs -RRB- from the olfactory bulb were capable to promote axonal regeneration and functional recovery when transplanted either acutely or 1 week delayed into the T8 transected rat	460
i Provincial , Universitat de Barcelona	460
i	460
Provincial , Universitat de Barcelona	462
Barcelona , Spain The present study was undertaken to determine whether olfactory ensheathing cells -LRB- OECs -RRB- from the olfactory bulb were capable to promote axonal regeneration and functional recovery when transplanted either acutely or 1 week delayed into the T8 transected rat	500
Barcelona , Spain	500
The present study	518
olfactory ensheathing cells -LRB- OECs -RRB- from the olfactory bulb	572
olfactory ensheathing cells -LRB- OECs -RRB-	572
olfactory ensheathing cells	572
OECs	601
the olfactory bulb	612
axonal regeneration	655
functional recovery when transplanted either acutely or 1 week delayed into the T8	679
functional recovery	679
transplanted	704
1 week	735
the T8	755
rat	773
OEC transplants	790
recovery of functional outcomes	816
recovery	816
functional outcomes	828
return of motor	884
return	884
motor	894
potentials	907
reduction of hindlimb hyperreflexia	925
reduction	925
hindlimb hyperreflexia	938
recovery of movements of hindlimb joints	982
recovery	982
movements of hindlimb joints	994
movements	994
hindlimb joints	1007
Axonal regeneration	1024
long axonal outgrowth of raphespinal , coerulospinal , and corticospinal tracts	1087
long axonal outgrowth	1087
raphespinal , coerulospinal , and corticospinal tracts	1112
the caudal cord stump	1172
Expression of GFAP and NG2	1195
Expression	1195
GFAP and NG2	1209
perilesional cord segments	1244
transplanted animals , indicating a more suitable environment for axonal regeneration	1274
transplanted animals	1274
a more suitable environment for axonal regeneration	1307
a more suitable environment	1307
axonal regeneration	1339
earlier recovery and better functional and histological results	1369
earlier recovery	1369
rats receiving acute than delayed OEC transplants	1450
rats	1450
delayed OEC transplants	1476
The beneficial effects obtained with transplantation after transection	1501
The beneficial effects	1501
transplantation	1538
transection	1560
the application of OECs in the human injured spinal cord	1592
the application	1592
OECs in the human injured spinal cord	1611
OECs	1611
the human injured spinal cord	1619
Introduction Spinal cord transection	1651
Introduction	1651
Spinal cord transection	1664
loss of central control of motor , sensory , and autonomic functions	1699
loss	1699
central control of motor , sensory , and autonomic functions	1707
central control	1707
motor , sensory , and autonomic functions	1726
motor	1726
sensory	1733
autonomic functions	1746
the site of injury	1772
the site	1772
injury	1784
Neuronal death together with failure of axons to regenerate across the injury site	1792
Neuronal death	1792
failure of axons to regenerate across the injury site	1821
failure	1821
axons to regenerate across the injury site	1832
the injury site	1859
permanent and irreversible deficits	1883
the patients	1922
axons	1945
the central nervous system	1976
they	2004
the ability	2016
long distances	2038
an appropriate cellular environment -LRB- David and Aguayo , 1981 -RRB-	2070
an appropriate cellular environment	2070
David and Aguayo	2107
1981	2125
Upregulation of proteoglycans -LRB- Asher et al. , 2001 -RRB- and myelin associated inhibitors -LRB- Schnell and Schwab , 1990 -RRB- , lack of adequate supply of neurotrophic factors -LRB- Tuszynski et al. , 1996 -RRB- , and formation of a glial scar -LRB- Fawcett and Asher , 1999 -RRB-	2132
Upregulation	2132
proteoglycans -LRB- Asher et al. , 2001 -RRB- and myelin associated inhibitors -LRB- Schnell and Schwab , 1990 -RRB- , lack of adequate supply of neurotrophic factors -LRB- Tuszynski et al. , 1996 -RRB- , and formation of a glial scar -LRB- Fawcett and Asher , 1999 -RRB-	2148
proteoglycans -LRB- Asher et al. , 2001 -RRB-	2148
proteoglycans	2148
Asher	2163
et al. , 2001	2169
et al.	2169
2001	2177
myelin associated inhibitors -LRB- Schnell and Schwab , 1990 -RRB- , lack of adequate supply of neurotrophic factors -LRB- Tuszynski et al. , 1996 -RRB- , and formation of a glial scar -LRB- Fawcett and Asher , 1999 -RRB-	2187
myelin associated inhibitors -LRB- Schnell and Schwab , 1990 -RRB-	2187
myelin associated inhibitors	2187
Schnell and Schwab	2217
1990	2237
lack of adequate supply of neurotrophic factors -LRB- Tuszynski et al. , 1996 -RRB-	2244
lack	2244
adequate supply of neurotrophic factors	2252
adequate supply	2252
neurotrophic factors	2271
Tuszynski	2293
et al. , 1996	2303
et al.	2303
1996	2311
formation of a glial scar -LRB- Fawcett and Asher , 1999 -RRB-	2322
formation	2322
a glial scar -LRB- Fawcett and Asher , 1999 -RRB-	2335
a glial scar	2335
Fawcett and Asher	2349
1999	2368
the main factors impeding axonal regeneration	2385
the main factors	2385
axonal regeneration	2411
Transplantation of olfactory ensheathing cell -LRB- OEC -RRB-	2432
Transplantation of olfactory ensheathing cell	2432
Transplantation	2432
olfactory ensheathing cell	2451
OEC	2479
one of the experimental treatments that have provided promising results	2487
one	2487
the experimental treatments that have provided promising results	2494
the experimental treatments	2494
promising results	2541
Previous works in our laboratory	2560
Previous works	2560
our laboratory	2578
OECs transplanted into the partially injured spinal cord	2605
OECs	2605
the partially injured spinal cord	2628
functional outcome	2670
neuroprotective effects -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Lo ' pez-Vales et al. , 2004 ; Verdu ' et al. , 2001 , 2003 -RRB-	2698
neuroprotective effects	2698
Garcı ' a-Alı ' as et al. , 2004 ; Lo ' pez-Vales et al. , 2004 ; Verdu ' et al. , 2001 , 2003	2723
Garcı ' a-Alı ' as et al. , 2004 ; Lo ' pez-Vales et al.	2723
Garcı ' a-Alı ' as et al. , 2004	2723
Garcı ' a-Alı	2723
et al.	2738
2004	2746
Lo ' pez-Vales et al.	2752
Lo ' pez-Vales	2752
Lo '	2752
et al.	2765
2004 ; Verdu ' et al.	2773
2004	2773
Verdu ' et al.	2779
Verdu '	2779
et al.	2786
2001 , 2003	2794
2001	2794
2003	2800
the mechanisms underlying the neuroprotective/regenerative properties of OECs	2816
the mechanisms	2816
the neuroprotective/regenerative properties of OECs	2842
the neuroprotective/regenerative properties	2842
OECs	2889
modulation of reactive astrocytes and reduction of proteoglycan expression -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Takami et al. , 2002 ; Verdu ' et al. , 2001 -RRB- , promotion of neoangiogenesis -LRB- Lo ' pez-Vales et al. , 2004 ; Ramer et al. , 2004b -RRB- , and release of neurotrophic factors by transplanted OECs -LRB- Woodhall et al. , 2001 -RRB-	2925
modulation	2925
reactive astrocytes and reduction of proteoglycan expression -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Takami et al. , 2002 ; Verdu ' et al. , 2001 -RRB- , promotion of neoangiogenesis -LRB- Lo ' pez-Vales et al. , 2004 ; Ramer et al. , 2004b -RRB- , and release of neurotrophic factors by transplanted OECs -LRB- Woodhall et al. , 2001 -RRB-	2939
reactive astrocytes	2939
reduction of proteoglycan expression -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Takami et al. , 2002 ; Verdu ' et al. , 2001 -RRB- , promotion of neoangiogenesis -LRB- Lo ' pez-Vales et al. , 2004 ; Ramer et al. , 2004b -RRB- , and release of neurotrophic factors by transplanted OECs -LRB- Woodhall et al. , 2001 -RRB-	2963
reduction	2963
proteoglycan expression -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Takami et al. , 2002 ; Verdu ' et al. , 2001 -RRB- , promotion of neoangiogenesis -LRB- Lo ' pez-Vales et al. , 2004 ; Ramer et al. , 2004b -RRB- , and release of neurotrophic factors	2976
proteoglycan expression -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Takami et al. , 2002 ; Verdu ' et al. , 2001 -RRB-	2976
proteoglycan expression	2976
Garcı ' a-Alı ' as et al. , 2004 ; Takami et al. , 2002 ; Verdu ' et al. , 2001	3001
Garcı ' a-Alı ' as et al. , 2004	3001
Garcı ' a-Alı	3001
et al.	3016
2004	3024
Takami et al. , 2002	3030
Takami	3030
et al. , 2002	3037
et al.	3037
2002	3045
Verdu ' et al. , 2001	3051
Verdu '	3051
et al. , 2001	3058
et al.	3058
2001	3066
promotion of neoangiogenesis -LRB- Lo ' pez-Vales et al. , 2004 ; Ramer et al. , 2004b -RRB-	3073
promotion of neoangiogenesis -LRB- Lo ' pez-Vales et al. , 2004 ; Ramer et al.	3073
promotion of neoangiogenesis -LRB- Lo ' pez-Vales et al. , 2004	3073
promotion	3073
neoangiogenesis -LRB- Lo '	3086
neoangiogenesis	3086
Lo	3103
et al. , 2004	3116
et al.	3116
2004	3124
Ramer et al.	3130
Ramer	3130
et al.	3136
2004b	3144
release of neurotrophic factors	3156
release	3156
neurotrophic factors	3167
transplanted OECs -LRB- Woodhall et al. , 2001 -RRB-	3191
transplanted OECs	3191
Woodhall	3210
et al. , 2001	3219
et al.	3219
2001	3227
the main beneficial actions	3248
addition to neuroprotection	3280
addition	3280
neuroprotection	3292
OECs	3309
axonal regeneration	3327
dorsal rhyzotomy -LRB- Navarro et al. , 1999 ; Ramo ' n-Cueto and Nieto - Sampedro , 1994 -RRB- and spinal cord injury -LRB- Keyvan-Fouladi et al. , 2003 ; Li et al. , 1998 ; Plant et al. , 2003 ; Ramer et al. , 2004a ; Ramo ' n - Cueto et al. , 2000 -RRB-	3353
dorsal rhyzotomy	3353
Navarro et al. , 1999 ; Ramo ' n-Cueto and Nieto - Sampedro , 1994	3371
Navarro	3371
et al. , 1999 ; Ramo ' n-Cueto and Nieto - Sampedro , 1994	3379
et al. , 1999	3379
et al.	3379
1999	3387
Ramo ' n-Cueto and Nieto	3393
Ramo ' n-Cueto	3393
Ramo '	3393
Nieto	3410
Sampedro , 1994	3417
Sampedro	3417
1994	3427
spinal cord injury	3437
Keyvan-Fouladi et al. , 2003 ; Li et al. , 1998 ; Plant et al. , 2003 ; Ramer et al. , 2004a ; Ramo ' n - Cueto et al. , 2000	3457
Keyvan-Fouladi	3457
et al. , 2003 ; Li et al. , 1998 ; Plant et al. , 2003 ; Ramer et al. , 2004a ; Ramo ' n - Cueto et al. , 2000	3472
et al. , 2003	3472
et al.	3472
2003	3480
Li et al. , 1998	3486
Li	3486
et al. , 1998	3489
et al.	3489
1998	3497
Plant et al. , 2003	3503
Plant	3503
et al. , 2003	3509
et al.	3509
2003	3517
Ramer et al. , 2004a	3523
Ramer	3523
et al. , 2004a	3529
et al.	3529
2004a	3537
Ramo ' n - Cueto et al. , 2000	3544
Ramo ' n	3544
Ramo '	3544
Cueto et al. , 2000	3552
Cueto	3552
et al. , 2000	3558
et al.	3558
2000	3566
collateral sprouting -LRB- Chuah et al. , 2004 -RRB- , and remyelination -LRB- Imaizumi et al. , 1998 ; Sasaki et al. , 2004 -RRB-	3573
collateral sprouting -LRB- Chuah et al. , 2004 -RRB-	3573
collateral sprouting	3573
collateral	3573
Chuah	3595
et al. , 2004	3601
et al.	3601
2004	3609
remyelination -LRB- Imaizumi et al. , 1998 ; Sasaki et al. , 2004 -RRB-	3620
remyelination	3620
Imaizumi	3635
et al. , 1998 ; Sasaki et al. , 2004	3644
et al.	3644
1998 ; Sasaki et al.	3652
1998	3652
Sasaki et al.	3658
Sasaki	3658
et al.	3665
2004	3673
other works	3694
the regenerative and neuroprotective effects of OEC grafts	3724
the regenerative and neuroprotective effects	3724
OEC grafts	3772
spinal cord injury -LRB- Andrews and Stelzner , 2004 ; Resnick et al. , 2003 ; Takami et al. , 2002 -RRB- or dorsal rhyzotomy -LRB- Ramer et al. , 2004b ; Riddell et al. , 2004 -RRB-	3789
spinal cord injury	3789
Andrews and Stelzner , 2004 ; Resnick et al. , 2003 ; Takami et al. , 2002	3809
Andrews and Stelzner	3809
2004 ; Resnick et al. , 2003 ; Takami et al.	3831
2004	3831
Resnick et al. , 2003 ; Takami et al.	3837
Resnick	3837
et al. , 2003 ; Takami et al.	3845
et al. , 2003	3845
et al.	3845
2003	3853
Takami et al.	3859
Takami	3859
et al.	3866
2002	3874
dorsal rhyzotomy	3883
Ramer	3901
et al. , 2004b ; Riddell et al. , 2004	3907
et al.	3907
2004b ; Riddell et al.	3915
2004b	3915
Riddell et al.	3922
Riddell	3922
et al.	3930
2004	3938
Differences in cell source -LRB- olfactory bulb , olfactory nerve layer or olfactory mucosa -RRB- , in protocols for cell culturing , purification and preservation , and in trauma models	3945
Differences	3945
cell source -LRB- olfactory bulb , olfactory nerve layer or olfactory mucosa -RRB-	3960
cell source	3960
olfactory bulb , olfactory nerve layer or olfactory mucosa	3973
olfactory bulb	3973
olfactory nerve layer	3989
olfactory mucosa	4014
protocols for cell culturing , purification and preservation ,	4036
protocols	4036
cell culturing , purification and preservation ,	4050
cell culturing	4050
purification and preservation	4066
trauma models	4104
differences in the results	4134
differences	4134
the results	4149
current controversy	4170
several clinical trials using OECs in human spinal cord injury	4191
several clinical trials	4191
OECs in human spinal cord injury	4221
OECs	4221
human spinal cord injury	4229
ongoing -LRB- Senior , 2002 -RRB-	4258
ongoing	4258
Senior	4267
2002	4275
Utilization of OECs in human spinal cord injury	4282
Utilization	4282
OECs in human spinal cord injury	4297
OECs	4297
human spinal cord injury	4305
there	4360
no concluding experimental studies assessing regeneration and functional recovery promoted by OECs transplanted into the injured spinal cord at different times postinjury -LRB- Keyvan-Fouladi et al. , 2003 ; Lu et al. , 2002 -RRB-	4370
no concluding experimental studies	4370
regeneration and functional recovery promoted by OECs transplanted into the injured spinal cord at different times postinjury -LRB- Keyvan-Fouladi et al. , 2003 ; Lu et al. , 2002 -RRB-	4415
regeneration and functional recovery	4415
OECs transplanted into the injured spinal cord at different times postinjury -LRB- Keyvan-Fouladi et al. , 2003 ; Lu et al. , 2002 -RRB-	4464
OECs	4464
the injured spinal cord at different times postinjury -LRB- Keyvan-Fouladi et al. , 2003 ; Lu et al. , 2002 -RRB-	4487
the injured spinal cord at different times postinjury	4487
the injured spinal cord at different times	4487
the injured spinal cord	4487
different times	4514
Keyvan-Fouladi	4542
et al. , 2003 ; Lu et al. , 2002	4557
et al.	4557
2003 ; Lu et al.	4565
2003	4565
Lu et al.	4571
Lu	4571
et al.	4574
2002	4582
The NINCDS guideline to conclude functional regeneration after spinal cord injury -LRB- Guth et al. , 1980 -RRB- required to prove by means of histological and electrophysiological methods the disconnection of nerve processes caused by the injury , to demonstrate axonal regeneration across the lesion site and postjunctional responses of regenerated fibers , and finally , to observe functional recovery	4589
functional regeneration	4622
spinal cord injury -LRB- Guth et al. , 1980 -RRB- required to prove by means of histological and electrophysiological methods the disconnection of nerve processes caused by the injury , to demonstrate axonal regeneration across the lesion site and postjunctional responses of regenerated fibers , and finally , to observe functional recovery	4652
spinal cord injury	4652
Guth	4672
et al. , 1980	4677
et al.	4677
1980	4685
means of histological and electrophysiological methods	4712
means	4712
histological and electrophysiological methods	4721
the disconnection of nerve processes caused by the injury	4767
the disconnection	4767
nerve processes caused by the injury	4788
nerve processes	4788
the injury	4814
axonal regeneration	4841
the lesion site and postjunctional responses of regenerated fibers	4868
the lesion site	4868
postjunctional responses of regenerated fibers	4888
postjunctional responses	4888
regenerated fibers	4916
functional recovery	4960
the new connections	4993
The present study	5014
the effects of OEC grafts	5053
the effects	5053
OEC grafts	5068
axonal regeneration and target reinnervation	5082
complete thoracic spinal cord transection in the adult rat using electrophysiological , functional , and immunohistochemical techniques	5133
complete thoracic spinal cord transection	5133
the adult rat using electrophysiological , functional , and immunohistochemical techniques	5178
the adult rat	5178
immunohistochemical techniques	5236
We	5268
the regenerative properties of OECs	5285
the regenerative properties	5285
OECs	5316
they	5326
1 week	5366
spinal cord transection	5387
addition	5415
we	5425
OEC transplants	5444
the expression of GFAP and NG2 , two well-known inhibitors of axonal regeneration	5481
the expression	5481
GFAP and NG2 , two well-known inhibitors of axonal regeneration	5499
GFAP and NG2	5499
two well-known inhibitors of axonal regeneration	5513
two well-known inhibitors	5513
axonal regeneration	5542
the central nervous system -LRB- Camand et al. , 2004 ; Fawcett and Asher , 1999 ; Tang et al. , 2003 -RRB-	5565
the central nervous system	5565
Camand et al. , 2004 ; Fawcett and Asher , 1999 ; Tang et al. , 2003	5593
Camand	5593
et al. , 2004 ; Fawcett and Asher , 1999 ; Tang et al. , 2003	5600
et al. , 2004	5600
et al.	5600
2004	5608
Fawcett and Asher , 1999	5614
Fawcett and Asher	5614
1999	5633
Tang et al. , 2003	5639
Tang	5639
et al. , 2003	5644
et al.	5644
2003	5652
Materials and methods The experimental procedures performed	5660
Materials	5660
methods The experimental procedures performed	5674
methods The experimental procedures	5674
methods	5674
The experimental procedures	5682
the recommendations of the European Union and the US Department of Health	5731
the recommendations of the European Union	5731
the recommendations	5731
the European Union	5754
the US Department of Health	5777
the US Department	5777
Health	5798
the care and use of laboratory animals	5809
the care and use	5809
laboratory animals	5829
the Ethics Committee of our institution	5869
the Ethics Committee	5869
our institution	5893
OEC cultures and immunopurification Primary olfactory bulb cultures were set up from 50 P22 -- P23 Sprague -- Dawley rats using the method described by Gudin˜o - Cabrera and Nieto-Sampedro -LRB- 1996 , 2000 -RRB- with minor modifications -LRB- Lo ' pez-Vales et al. , 2004 ; Verdu ' et al. , 2003 -RRB- .	5910
OEC cultures and immunopurification Primary olfactory bulb cultures were set up from 50 P22	5910
OEC cultures and immunopurification	5910
Primary olfactory bulb cultures	5946
50 P22	5995
P23 Sprague	6002
P23	6002
Sprague	6006
Dawley rats using the method described by Gudin˜o - Cabrera and Nieto-Sampedro -LRB- 1996 , 2000 -RRB- with minor modifications -LRB- Lo ' pez-Vales et al. , 2004 ; Verdu ' et al. , 2003 -RRB-	6014
Dawley rats	6014
the method described by Gudin˜o - Cabrera and Nieto-Sampedro -LRB- 1996 , 2000 -RRB- with minor modifications -LRB- Lo ' pez-Vales et al. , 2004 ; Verdu ' et al. , 2003 -RRB-	6032
the method	6032
Gudin˜o - Cabrera and Nieto-Sampedro -LRB- 1996 , 2000 -RRB- with minor modifications -LRB- Lo '	6056
Gudin˜o	6056
Cabrera and Nieto-Sampedro -LRB- 1996 , 2000 -RRB- with minor modifications -LRB- Lo '	6065
Cabrera and Nieto-Sampedro -LRB- 1996 , 2000 -RRB-	6065
Cabrera and Nieto-Sampedro	6065
1996	6093
2000	6099
minor modifications -LRB- Lo '	6110
minor modifications	6110
Lo	6131
pez-Vales et al.	6134
2004 ; Verdu ' et al. , 2003	6152
2004	6152
Verdu ' et al. , 2003	6158
Verdu '	6158
et al. , 2003	6165
et al.	6165
2003	6173
olfactory bulbs	6189
the meningeal layer	6219
fine forceps	6261
the bulbs	6278
The cell mixture	6343
centrifugation	6377
flasks pre-coated with poly-l-lysine -LRB- 10 Ag/ml , Sigma , St. Louis , USA -RRB-	6406
flasks pre-coated with poly-l-lysine	6406
flasks	6406
poly-l-lysine	6429
10 Ag/ml , Sigma , St. Louis , USA	6444
10 Ag/ml	6444
Sigma	6454
St. Louis	6461
USA	6472
A defined medium	6478
the OECs	6518
confluence -LRB- 7 -- 9 days in vitro -RRB-	6543
confluence	6543
7	6555
9 days in vitro	6557
9 days	6557
vitro	6567
OECs	6575
means of magnetic Dynabeads M-450 -LRB- Dynal , Oslo , Norway -RRB-	6616
means of magnetic Dynabeads M-450	6616
means	6616
magnetic Dynabeads	6625
Dynal	6651
Oslo	6658
Norway	6664
goat anti-mouse IgG	6688
mouse	6726
monoclonal 192 IgG antibodies -LRB- MAB365 , Chemicon , Temecula , CA -RRB- that recognize the p75-NGF receptor	6732
monoclonal 192 IgG antibodies	6732
192	6743
MAB365	6763
Chemicon	6771
Temecula , CA	6781
the p75-NGF receptor	6810
The p75-positive OECs	6832
freezing medium -LRB- C-6295 , Sigma -RRB-	6874
freezing medium	6874
C-6295	6891
Sigma	6899
-20 °C for 10 min	6925
-20 °C	6925
10 min	6935
a deep freezer at -80 °C	6951
a deep freezer	6951
-80 °C	6969
transplantation	6980
frozen cell vials	6997
37 °C , washed two times by centrifugation -LRB- 900 rpm , 7 min -RRB- in DMEM/F12 , and the pellet resuspended in the same medium	7030
37 °C	7030
two times	7043
centrifugation	7056
900 rpm , 7 min	7072
900 rpm	7072
7 min	7081
DMEM/F12	7091
the pellet resuspended in the same medium	7105
the pellet	7105
the same medium	7131
The cells	7148
2 h of thawing	7183
2 h	7183
thawing	7190
It	7199
frozen and thawed OECs	7240
active migration and integration in the central nervous tissue	7268
active migration and integration	7268
the central nervous tissue	7304
Gudin˜o	7332
Cabrera and Nieto-Sampedro , 1996 , 2000 ; Verdu ' et al. , 2001	7340
Cabrera and Nieto-Sampedro	7340
1996	7368
2000 ; Verdu ' et al. , 2001	7374
2000	7374
Verdu ' et al. , 2001	7380
Verdu '	7380
et al. , 2001	7387
et al.	7387
2001	7395
Surgical procedure Female adult Sprague -- Dawley rats -LRB- 250 -- 300 g -RRB-	7402
Surgical procedure Female adult Sprague -- Dawley rats	7402
Surgical procedure	7402
Female adult Sprague -- Dawley rats	7421
Dawley	7442
250 -- 300 g	7455
250	7455
300 g	7459
40 mg/kg , i.p.	7504
40 mg/kg	7504
laminectomy to expose the T8 -- T9 thoracic spinal cord segments	7527
the T8 -- T9 thoracic spinal cord segments	7549
the T8	7549
T9 thoracic spinal cord segments	7556
T9	7556
thoracic spinal cord segments	7559
the cord	7590
T8	7628
microscissors	7637
The rostral and caudal stumps	7652
The rostral	7652
caudal stumps	7668
complete transection	7717
transplantation	7743
a suspension of OECs	7760
a suspension	7760
OECs	7776
a sterile glass needle -LRB- 80 µm i.d. ; 100 µm o.d. -RRB- connected to a Hamilton syringe	7815
a sterile glass needle -LRB- 80 µm i.d. ; 100 µm o.d. -RRB-	7815
a sterile glass needle	7815
80 µm i.d. ; 100 µm o.d.	7839
80 µm i.d.	7839
100 µm o.d.	7851
a Hamilton syringe	7877
Rats	7897
four injections of OECs -LRB- 375,000 cells in 3 µl each -RRB- , two injections 1 mm cranial and two 1 mm caudal to the lesion epicenter , and at each level one injection at each side 0.5 mm lateral to the cord midline	7911
four injections of OECs -LRB- 375,000 cells in 3 µl each -RRB-	7911
four injections	7911
OECs -LRB- 375,000 cells in 3 µl each -RRB-	7930
OECs	7930
375,000 cells in 3 µl each	7936
375,000 cells	7936
3 µl each	7953
3 µl	7953
each	7958
two injections 1 mm cranial	7965
two injections	7965
1 mm cranial	7980
two 1 mm caudal to the lesion epicenter , and at each level one injection at each side 0.5 mm lateral to the cord midline	7997
two 1 mm caudal	7997
the lesion epicenter	8016
each level one injection at each side 0.5 mm lateral to the cord midline	8045
each level one injection	8045
each side 0.5 mm lateral to the cord midline	8073
each side 0.5 mm lateral	8073
the cord midline	8101
0.5 mm depth -LRB- Lo ' pez-Vales et al. , 2004 -RRB-	8121
0.5 mm depth	8121
Lo ' pez-Vales et al. , 2004	8135
Lo '	8135
pez-Vales et al. , 2004	8138
et al. , 2004	8148
et al.	8148
2004	8156
Each transplanted rat	8163
a total of 1,500,000 cells	8194
a total	8194
1,500,000 cells	8205
OEC grafts	8222
30 min after the lesion -LRB- OECac group ; n = 8 -RRB-	8260
30 min	8260
the lesion -LRB- OECac group ; n = 8 -RRB-	8273
the lesion	8273
OECac group ; n = 8	8285
OECac group	8285
n = 8	8298
n	8298
8	8302
7 days -LRB- OECdl group ; n = 8 -RRB-	8317
7 days	8317
OECdl group ; n = 8	8325
OECdl group	8325
n = 8	8338
n	8338
8	8342
Control animals	8346
12 µl of DMEM / F12 distributed at the same coordinates at 30 min -LRB- DMac group ; n = 8 -RRB- or 7 days postinjury -LRB- DMdl group ; n = 8 -RRB-	8371
12 µl	8371
DMEM	8380
F12 distributed at the same	8386
F12	8386
the same	8405
30 min -LRB- DMac group ; n = 8 -RRB- or 7 days	8429
30 min -LRB- DMac group ; n = 8 -RRB-	8429
DMac group ; n = 8	8437
DMac group	8437
n = 8	8449
n	8449
8	8453
7 days	8459
postinjury -LRB- DMdl group ; n = 8 -RRB-	8466
postinjury	8466
DMdl group ; n = 8	8478
DMdl group	8478
n = 8	8490
n	8490
8	8494
All rats	8498
a 12-h light/dark cycle	8523
water and food ad libitum	8560
Bladders	8587
twice a day	8611
reflex voiding of the bladder	8629
reflex voiding	8629
the bladder	8647
Behavioral assessment Locomotor activity	8676
the open-field walking test	8737
the locomotor ability	8776
5 min	8805
One animal at a time	8812
One animal	8812
a time	8826
a circular plastic tray -LRB- 90 cm diameter x 24 cm wall height -RRB-	8867
a circular plastic tray	8867
90 cm diameter x 24 cm wall height	8892
90 cm diameter	8892
24 cm wall height	8909
Two independent examiners	8929
the hindlimb movements of the rat	8964
the hindlimb movements	8964
the rat	8990
the locomotor function	9010
the Basso , Beattie , and Bresnahan scale -LRB- BBB scale -RRB- that ranges from 0 -LRB- paralysis -RRB- to 21 points -LRB- normal gait -RRB- -LRB- Basso et al. , 1995 -RRB-	9046
the Basso	9046
Beattie	9057
Bresnahan scale -LRB- BBB scale -RRB- that ranges from 0 -LRB- paralysis -RRB- to 21 points -LRB- normal gait -RRB- -LRB- Basso et al. , 1995 -RRB-	9070
Bresnahan scale	9070
BBB scale	9087
0 -LRB- paralysis -RRB- to 21 points -LRB- normal gait -RRB- -LRB- Basso et al. , 1995 -RRB-	9115
0 -LRB- paralysis -RRB-	9115
21 points -LRB- normal gait -RRB- -LRB- Basso et al. , 1995 -RRB-	9132
21 points -LRB- normal gait -RRB-	9132
21 points	9132
normal gait	9143
Basso	9157
et al. , 1995	9163
et al.	9163
1995	9171
The final score of each animal	9178
The final score	9178
each animal	9197
the mean value of both examiners	9213
the mean value	9213
both examiners	9231
The climbing test	9247
voluntary hindlimb motor function -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	9291
voluntary hindlimb motor function	9291
Ramo ' n-Cueto et al. , 2000	9326
Ramo ' n-Cueto et al.	9326
Ramo ' n-Cueto	9326
Ramo '	9326
2000	9347
animals	9363
a grid -LRB- 12.5 ± 12.5 mm holes -RRB- inclined at 45 - , 60 -	9398
a grid -LRB- 12.5 ± 12.5 mm holes -RRB-	9398
a grid	9398
12.5 ± 12.5 mm holes	9406
12.5 ±	9406
12.5 mm holes	9413
45	9440
60	9445
90	9454
a horizontal platform	9473
The higher grid angle	9496
Rats	9539
the BBB score and the climbing test	9564
the BBB score	9564
the climbing test	9582
1 week	9600
injury	9613
5 months	9640
9 months	9657
Electrophysiological evaluation Electrophysiological tests	9667
all rats	9744
surgery	9762
monthly intervals until 5 months , and at 9 months postinjury	9774
monthly intervals	9774
5 months	9798
9 months	9815
postinjury	9824
Motor	9836
potentials -LRB- MEPs -RRB-	9849
potentials	9849
MEPs	9861
regeneration of spinal cord descending tracts -LRB- Garcı ' a-Alı ' as et al. , 2003 -RRB-	9889
regeneration	9889
spinal cord descending tracts	9905
Garcı ' a-Alı ' as et al. , 2003	9936
Garcı '	9936
a-Alı ' as et al. , 2003	9942
a-Alı	9942
et al.	9951
2003	9959
MEPs	9966
supramaximal electrical stimulation -LRB- single pulses of 0.1 ms duration and 25 mA intensity -RRB- of the motor cortex	9986
supramaximal electrical stimulation -LRB- single pulses of 0.1 ms duration and 25 mA intensity -RRB-	9986
supramaximal electrical stimulation	9986
single pulses of 0.1 ms	10023
single pulses	10023
0.1 ms	10040
duration and 25 mA intensity	10047
the motor cortex	10080
needle electrodes inserted subcutaneously , the cathode over the skull overlying the motor area and the anode at the nose , and recorded from the contralateral gastrocnemius muscle	10105
needle electrodes	10105
the cathode over the skull	10148
the cathode	10148
the skull	10165
the motor area and the anode	10185
the motor area	10185
the anode	10204
the nose	10217
the contralateral gastrocnemius muscle	10245
The signals	10285
the oscilloscope -LRB- Sapphire 4ME , Vickers -RRB- to measure the amplitude and the latency of the evoked potentials	10340
the oscilloscope -LRB- Sapphire 4ME , Vickers -RRB- to measure the amplitude	10340
Sapphire 4ME	10358
Vickers	10372
the amplitude	10392
the latency of the evoked potentials	10410
the latency	10410
the evoked potentials	10425
the	10425
potentials	10436
The non-invasive method applied	10448
The non-invasive method	10448
consistent evaluation of MEPs in the same animal	10487
consistent evaluation	10487
MEPs in the same animal	10512
MEPs	10512
the same animal	10520
time -LRB- Garcı ' a-Alı ' as et al. , 2003 ; Valero-Cabre ' et al. , 2004 -RRB-	10552
time	10552
Garcı ' a-Alı ' as et al. , 2003 ; Valero-Cabre ' et al. , 2004	10558
Garcı ' a-Alı ' as et al. , 2003 ; Valero-Cabre ' et al. ,	10558
Garcı ' a-Alı	10558
et al.	10573
2003 ; Valero-Cabre ' et al. ,	10581
2003	10581
Valero-Cabre ' et al.	10587
Valero-Cabre '	10587
et al.	10601
2004	10609
lumbar spinal reflexes	10626
the sciatic nerve	10650
single electrical pulses of 0.1-ms duration up to supramaximal intensity delivered by monopolar needles inserted percutaneously at the sciatic notch	10688
single electrical pulses	10688
0.1-ms duration up to supramaximal intensity delivered by monopolar needles inserted percutaneously at the sciatic notch	10716
0.1-ms duration	10716
supramaximal intensity	10738
monopolar needles inserted percutaneously at the sciatic notch	10774
monopolar needles	10774
the sciatic notch	10819
Compound muscle action potentials , including the direct muscle response -LRB- M-wave -RRB- and the monosynaptic reflex response -LRB- H-wave -RRB- , of the plantar muscles	10838
Compound muscle action potentials , including the direct muscle response -LRB- M-wave -RRB- and the monosynaptic reflex response -LRB- H-wave -RRB- ,	10838
Compound muscle action potentials	10838
the direct muscle response -LRB- M-wave -RRB- and the monosynaptic reflex response -LRB- H-wave -RRB-	10883
the direct muscle response	10883
M-wave	10911
the monosynaptic reflex response	10923
H-wave	10957
the plantar muscles	10969
means of needle electrodes	11006
means	11006
needle electrodes	11015
the oscilloscope	11061
the amplitude and the latency of M - and H-waves -LRB- Navarro et al. , 1999 ; Valero-Cabre ' et al. , 2004 -RRB-	11089
the amplitude	11089
the latency of M	11107
the latency	11107
M	11122
H-waves -LRB- Navarro et al. , 1999 ; Valero-Cabre ' et al. , 2004 -RRB-	11129
H-waves	11129
Navarro	11138
et al. , 1999 ; Valero-Cabre ' et al. , 2004	11146
et al.	11146
1999 ; Valero-Cabre ' et al.	11154
1999	11154
Valero-Cabre ' et al.	11160
Valero-Cabre '	11160
et al.	11174
2004	11182
The H/M amplitude ratio	11189
The H/M ratio	11229
either partial or complete spinal cord injury -LRB- Malmsten , 1983 ; Valero-Cabre ' et al. , 2004 -RRB- , indicating H-reflex facilitation due to interruption of supraspinal motor control	11259
spinal cord injury -LRB- Malmsten , 1983 ; Valero-Cabre ' et al. , 2004 -RRB- , indicating H-reflex facilitation due to interruption of supraspinal motor control	11286
spinal cord injury	11286
Malmsten , 1983 ; Valero-Cabre ' et al. , 2004	11306
Malmsten	11306
1983 ; Valero-Cabre ' et al.	11316
1983	11316
Valero-Cabre ' et al.	11322
Valero-Cabre '	11322
et al.	11336
2004	11344
H-reflex facilitation	11362
interruption of supraspinal motor control	11391
interruption	11391
supraspinal motor control	11407
the corticospinal tract	11445
corticospinal axons	11487
the lesion site	11538
the corticospinal tract	11555
biotin dextran amine -LRB- BDA ; 10,000 MW ; Molecular Probes , Eugene , OR -RRB-	11610
biotin dextran amine	11610
BDA ; 10,000 MW ; Molecular Probes	11632
BDA	11632
10,000 MW ; Molecular Probes	11637
10,000 MW	11637
Molecular Probes	11648
Eugene , OR	11666
Eugene	11666
OR	11674
9 months after injury	11682
9 months	11682
injury	11697
rats	11705
anesthetized , placed in a stereotaxic frame	11715
anesthetized	11715
a stereotaxic frame	11739
two holes	11764
the cranium	11792
both sensorimotor cortices	11814
a single injection per hemisphere of 1 Al of a 10 % BDA solution in 0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11848
a single injection	11848
hemisphere of 1 Al of a 10 % BDA solution in 0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11871
hemisphere	11871
1 Al of a 10 % BDA solution in 0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11885
1 Al	11885
a 10 % BDA solution in 0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11893
a 10 % BDA solution	11893
0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11915
0.01 M phosphate buffer	11915
pH 7.2	11940
0.5 mm caudal and 2.5 mm lateral	11960
0.5 mm caudal	11960
2.5 mm lateral	11978
bregma	11998
a depth of 1.5 mm from skull surface , using a 10-Al Hamilton syringe that remained in place for 2 min after injection -LRB- Schucht et al. , 2002 -RRB-	12009
a depth	12009
1.5 mm	12020
skull surface	12032
a 10-Al Hamilton syringe	12053
place for 2 min	12095
place	12095
2 min	12105
injection -LRB- Schucht et al. , 2002 -RRB-	12117
injection	12117
Schucht	12128
et al. , 2002	12136
et al.	12136
2002	12144
BDA-labeled corticospinal axons	12151
Cy2 or Cy3	12208
avidin -- biotin complex -LRB- 1:200 , Jackson Immunoresearch , West Grove , PA -RRB-	12230
avidin	12230
biotin complex -LRB- 1:200 , Jackson Immunoresearch , West Grove , PA -RRB-	12237
biotin complex	12237
1:200 , Jackson Immunoresearch , West Grove , PA	12253
1:200	12253
Jackson Immunoresearch	12260
West Grove	12284
PA	12296
Histological evaluation Two weeks following BDA injection , rats	12301
Histological evaluation Two weeks	12301
BDA injection , rats	12345
BDA injection	12345
rats	12360
4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	12399
4 % paraformaldehyde	12399
0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	12422
0.1 M phosphate buffer	12422
pH 7.4	12446
Spinal cord	12455
T6 -- T10 , T10 -- T13 , and L1 -- S6 were removed , post-fixed overnight in the same fixative , and cryoprotected in 30 % sucrose at 4-C	12479
T6 -- T10 , T10 -- T13 , and L1 -- S6 were removed	12479
T6	12479
T10 , T10 -- T13 , and L1	12482
T10	12482
T10 -- T13	12487
T10	12487
T13	12491
L1	12500
S6	12503
post-fixed overnight in the same fixative , and cryoprotected in 30 % sucrose at 4-C	12520
post-fixed overnight in the same fixative , and cryoprotected in 30 % sucrose	12520
the same fixative	12544
30 %	12584
4-C	12599
Spinal cord segments	12604
TissueTek -LRB- Sakumura , Netherlands -RRB- , cut	12642
Sakumura	12653
Netherlands	12663
the sagital plane	12693
15	12712
thickness	12718
a cryostat	12732
gelatin-coated glass slides	12763
several washes with trizma-buffer saline -LRB- TBS , 0.1 M , pH 7.4 -RRB-	12798
several washes	12798
trizma-buffer saline -LRB- TBS , 0.1 M , pH 7.4 -RRB-	12818
trizma-buffer saline	12818
TBS	12840
0.1 M	12845
pH 7.4	12852
sections	12861
TBS with 0.5 % Triton X-100 -LRB- Fluka , Madrid , Spain -RRB- and 5 % FCS -LRB- Biological Industries , Israel -RRB- for 1 h and then overnight	12888
TBS with 0.5 % Triton X-100 -LRB- Fluka , Madrid , Spain -RRB-	12888
TBS	12888
0.5 % Triton X-100 -LRB- Fluka , Madrid , Spain -RRB-	12897
0.5 % Triton X-100	12897
Fluka	12916
Madrid	12923
Spain	12931
5 % FCS -LRB- Biological Industries , Israel -RRB- for 1 h and then overnight	12942
5 % FCS -LRB- Biological Industries , Israel -RRB-	12942
5 % FCS	12942
Biological Industries , Israel	12950
Biological Industries	12950
Israel	12973
1 h and then overnight	12985
1 h	12985
then overnight	12993
4 °C with primary antibodies	13011
4 °C	13011
primary antibodies	13020
The following antibodies	13040
: rabbit polyclonal antibodies against calcitonin gene-related peptide -LRB- CGRP ; AB1971 ; 1:400 , Chemicon -RRB- , dopamine h-hydroxylase -LRB- DhOH ; 1:100 , Diasorin , Stillwater , MN -RRB- , growth-associated protein -LRB- GAP-43 ; AB 5220 ; 1:500 , Chemicon -RRB- , neurofilament -LRB- NF-200 ; N-4142 ; 1:400 , Sigma -RRB- , serotonin -LRB- 5HT ; 1:100 , Diasorin -RRB- , mouse monoclonal antibodies against glial fibrillary acidic protein -LRB- GFAP ; G-3893 , 1:2000 ; Sigma -RRB- , NG2 -LRB- MAB5385 ; 1:100 , Chemicon -RRB- , and p75 neurotrophin receptor -LRB- p75NTR ; MAB365 , 1:200 , Chemicon -RRB- , and goat polyclonal antibody against choline acetyltransferase -LRB- ChAT ; AB 144P , 1:50 , Chemicon -RRB-	13074
: rabbit polyclonal antibodies against calcitonin gene-related peptide -LRB- CGRP ; AB1971 ; 1:400 , Chemicon -RRB- , dopamine h-hydroxylase -LRB- DhOH ; 1:100 , Diasorin , Stillwater , MN -RRB- , growth-associated protein -LRB- GAP-43 ; AB 5220 ; 1:500 , Chemicon -RRB- , neurofilament -LRB- NF-200 ; N-4142 ; 1:400 , Sigma -RRB- , serotonin -LRB- 5HT ; 1:100 , Diasorin -RRB- , mouse monoclonal antibodies against glial fibrillary acidic protein -LRB- GFAP ; G-3893 , 1:2000 ; Sigma -RRB- , NG2 -LRB- MAB5385 ; 1:100 , Chemicon -RRB- , and p75 neurotrophin receptor -LRB- p75NTR ; MAB365 , 1:200 , Chemicon -RRB-	13074
rabbit polyclonal antibodies against calcitonin gene-related peptide -LRB- CGRP ; AB1971 ; 1:400 , Chemicon -RRB-	13076
rabbit polyclonal antibodies	13076
calcitonin gene-related peptide -LRB- CGRP ; AB1971 ; 1:400 , Chemicon -RRB-	13113
calcitonin gene-related peptide	13113
CGRP ; AB1971 ; 1:400 , Chemicon	13146
CGRP	13146
AB1971 ; 1:400 , Chemicon	13152
AB1971	13152
1:400 , Chemicon	13160
1:400	13160
Chemicon	13167
dopamine h-hydroxylase -LRB- DhOH ; 1:100 , Diasorin , Stillwater , MN -RRB- , growth-associated protein -LRB- GAP-43 ; AB 5220 ; 1:500 , Chemicon -RRB- , neurofilament -LRB- NF-200 ; N-4142 ; 1:400 , Sigma -RRB- , serotonin -LRB- 5HT ; 1:100 , Diasorin -RRB- , mouse monoclonal antibodies against glial fibrillary acidic protein -LRB- GFAP ; G-3893 , 1:2000 ; Sigma -RRB- , NG2 -LRB- MAB5385 ; 1:100 , Chemicon -RRB- , and p75 neurotrophin receptor -LRB- p75NTR ; MAB365 , 1:200 , Chemicon -RRB-	13178
dopamine h-hydroxylase -LRB- DhOH ; 1:100 , Diasorin , Stillwater , MN -RRB-	13178
dopamine h-hydroxylase	13178
DhOH ; 1:100	13202
DhOH	13202
1:100	13208
Diasorin , Stillwater , MN	13215
Diasorin , Stillwater	13215
MN	13237
growth-associated protein -LRB- GAP-43 ; AB 5220 ; 1:500 , Chemicon -RRB-	13242
growth-associated protein	13242
GAP-43 ; AB 5220 ; 1:500 , Chemicon	13269
GAP-43	13269
AB 5220 ; 1:500 , Chemicon	13277
AB 5220	13277
1:500 , Chemicon	13286
1:500	13286
Chemicon	13293
neurofilament -LRB- NF-200 ; N-4142 ; 1:400 , Sigma -RRB-	13304
neurofilament	13304
NF-200 ; N-4142 ; 1:400 , Sigma	13319
NF-200	13319
N-4142 ; 1:400 , Sigma	13327
N-4142	13327
1:400 , Sigma	13335
1:400	13335
Sigma	13342
serotonin -LRB- 5HT ; 1:100 , Diasorin -RRB-	13350
serotonin	13350
5HT ; 1:100 , Diasorin	13361
5HT	13361
1:100 , Diasorin	13366
1:100	13366
Diasorin	13373
mouse monoclonal antibodies against glial fibrillary acidic protein -LRB- GFAP ; G-3893 , 1:2000 ; Sigma -RRB-	13384
mouse monoclonal antibodies	13384
glial fibrillary acidic protein	13420
GFAP ; G-3893	13453
GFAP	13453
G-3893	13459
1:2000 ; Sigma	13467
1:2000	13467
Sigma	13475
NG2 -LRB- MAB5385 ; 1:100 , Chemicon -RRB-	13483
NG2	13483
MAB5385 ; 1:100 , Chemicon	13488
MAB5385	13488
1:100 , Chemicon	13497
1:100	13497
Chemicon	13504
p75 neurotrophin receptor -LRB- p75NTR ; MAB365 , 1:200 , Chemicon -RRB-	13519
p75 neurotrophin receptor	13519
p75NTR ; MAB365	13546
p75NTR	13546
MAB365	13554
1:200 , Chemicon	13562
1:200	13562
Chemicon	13569
goat polyclonal antibody against choline acetyltransferase -LRB- ChAT ; AB 144P , 1:50 , Chemicon -RRB-	13584
goat polyclonal antibody	13584
choline acetyltransferase -LRB- ChAT ; AB 144P , 1:50 , Chemicon -RRB-	13617
choline acetyltransferase	13617
ChAT ; AB 144P	13644
ChAT	13644
AB 144P	13650
1:50 , Chemicon	13659
1:50	13659
Chemicon	13665
washes	13682
sections	13690
Cy2 or Cy3	13719
immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch -RRB-	13741
immunoglobulin G	13741
1:200	13759
Jackson Immunoresearch	13766
3 h	13794
room temperature	13801
additional washes with TBS	13829
additional washes	13829
TBS	13852
sections	13857
ethanol	13885
DPX -LRB- Fluka -RRB-	13915
DPX	13915
Fluka	13920
negative controls	13932
some sections	13951
the omission of primary antibodies	13998
the omission	13998
primary antibodies	14014
Images occupying most of the dorso-ventral axis of the spinal cord	14034
Images	14034
most of the dorso-ventral axis of the spinal cord	14051
most	14051
the dorso-ventral axis of the spinal cord	14059
the dorso-ventral axis	14059
the spinal cord	14085
200x magnification from the lesion epicenter -LRB- except for GFAP staining due to lack of labeling in this region -RRB- , as well as 1 mm cranial and 1 mm caudal	14115
200x magnification from the lesion epicenter -LRB- except for GFAP staining due to lack of labeling in this region -RRB-	14115
200x magnification	14115
the lesion epicenter -LRB- except for GFAP staining due to lack of labeling in this region -RRB-	14139
the lesion epicenter	14139
GFAP staining due to lack of labeling in this region	14172
GFAP staining	14172
lack of labeling in this region	14193
lack	14193
labeling in this region	14201
labeling	14201
this region	14213
1 mm cranial and 1 mm caudal	14238
1 mm cranial	14238
1 mm caudal	14255
the lesion edge	14270
Images	14287
the aid of a digital camera -LRB- Olympus DP50 -RRB- attached to the microscope and then , analyzed using NIH Image software for Apple Computers -LRB- version 1.6 -RRB-	14310
the aid	14310
a digital camera -LRB- Olympus DP50 -RRB-	14321
a digital camera	14321
Olympus DP50	14339
the microscope and then	14365
the microscope	14365
then	14384
NIH Image software for Apple Computers -LRB- version 1.6 -RRB-	14405
NIH Image software	14405
Apple Computers -LRB- version 1.6 -RRB-	14428
Apple Computers	14428
version 1.6	14445
Fiber quantification	14459
the number of pixels occupied by stained fibers per area -LRB- µm2 -RRB- after defining a threshold for background correction -LRB- Bradburry et al. , 1999 -RRB-	14508
the number	14508
pixels occupied by stained fibers per area -LRB- µm2 -RRB- after defining a threshold for background correction -LRB- Bradburry et al. , 1999 -RRB-	14522
pixels	14522
fibers per area -LRB- µm2 -RRB-	14549
fibers	14549
area -LRB- µm2 -RRB-	14560
area	14560
µm2	14566
a threshold for background correction -LRB- Bradburry et al. , 1999 -RRB-	14586
a threshold	14586
background correction -LRB- Bradburry et al. , 1999 -RRB-	14602
background correction	14602
Bradburry	14625
et al. , 1999	14635
et al.	14635
1999	14643
GFAP and NG2 staining quantification	14654
the intensity of labeling ranging on a scale between 0 -LRB- no fluorescence -RRB- and 255 -LRB- maximal fluorescence -RRB-	14692
the intensity	14692
a scale between 0 -LRB- no fluorescence -RRB- and 255 -LRB- maximal fluorescence -RRB-	14729
a scale	14729
0 -LRB- no fluorescence -RRB- and 255 -LRB- maximal fluorescence -RRB-	14745
0	14745
no fluorescence	14748
255	14769
maximal fluorescence	14774
Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. , 2001	14810
Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. ,	14810
Garcı ' a-Alı	14810
et al.	14825
2004 ; Plant et al. ,	14833
2004	14833
Plant et al.	14839
Plant	14839
et al.	14845
2001	14853
quantitative analysis	14864
series of eight spinal cord sections -LRB- 15 µm thick -RRB- separated by 135-µm intervals	14887
series	14887
eight spinal cord sections -LRB- 15 µm thick -RRB- separated by 135-µm intervals	14897
eight spinal cord sections	14897
15 µm	14925
135-µm intervals	14951
the above-indicated markers in each rat	14987
the above-indicated markers	14987
each rat	15018
each animal	15032
the immunoreactivity degree per marker	15045
the immunoreactivity degree	15045
marker	15077
the mean obtained in 12 serial sections	15088
the mean	15088
12 serial sections	15109
each group	15139
a mean value	15151
the average of each animal value	15182
the average	15182
each animal value	15197
variability	15235
sections from the different groups	15248
sections	15248
the different groups	15262
each marker	15317
the setting for image acquisition	15334
the setting	15334
image acquisition	15350
the same for all the images	15372
the same	15372
all the images	15385
Statistical analysis Functional , electrophysiological , and histological measurements	15401
Statistical analysis Functional	15401
electrophysiological , and histological measurements	15434
a blinded manner regarding the treatment received by each rat	15504
a blinded manner	15504
the treatment received by each rat	15531
the treatment	15531
each rat	15557
Data	15567
the mean T SEM	15589
Statistical comparisons between groups	15605
Statistical comparisons	15605
groups	15637
nonparametric Kruskal -- Wallis and Mann -- Whitney	15657
Wallis and Mann	15679
U tests	15703
Differences	15712
P	15755
Regression analysis	15765
relationships	15802
electrophysiological and functional results	15824
functional and histological results	15880
individual animals	15921
Chi-square analysis	15941
the proportion of rats showing MEPs restitution in each group	15981
the proportion	15981
rats showing MEPs restitution in each group	15999
rats	15999
MEPs restitution in each group	16012
MEPs restitution	16012
each group	16032
Results Table 1 Results of the amplitude of MEPs recorded in the gastrocnemius muscle , and of M - and H-waves	16045
Results	16045
Table 1 Results of the amplitude of MEPs	16053
Table 1 Results	16053
the amplitude of MEPs	16072
the amplitude	16072
MEPs	16089
the gastrocnemius muscle	16106
M	16139
plantar muscles found in electrophysiological tests performed before injury and at 9 months after spinal cord transection in the different experimental groups Fig. 1	16166
plantar muscles	16166
electrophysiological tests performed before injury and at 9 months after spinal cord transection in the different experimental groups Fig. 1	16191
electrophysiological tests	16191
injury	16235
9 months after spinal cord transection in the different experimental groups Fig.	16249
9 months	16249
spinal cord transection in the different experimental groups Fig.	16264
spinal cord transection	16264
the different experimental groups Fig.	16291
1	16331
Representative electrophysiological recordings of MEPs in intact animals -LRB- A -RRB- and in spinal cord transected animals -LRB- B -- F -RRB- .	16334
Representative electrophysiological recordings	16334
MEPs	16384
intact animals -LRB- A -RRB-	16392
intact animals	16392
A	16408
spinal cord	16418
transected animals -LRB- B -- F -RRB-	16430
transected animals	16430
B -- F	16450
B	16450
F	16453
the change of vertical scale in recording A and recordings B -- F	16462
the change	16462
vertical scale in recording A and recordings B -- F	16476
vertical scale	16476
recording A and recordings B -- F	16494
recording A and recordings B	16494
F	16523
injury	16532
MEPs	16540
the 9-month follow-up in DM-injected animals -LRB- B -RRB-	16583
the 9-month follow-up	16583
DM-injected animals -LRB- B -RRB-	16608
DM-injected animals	16608
B	16629
Representative MEPs	16633
first	16658
one OECac rat at 2 months postlesion -LRB- C -RRB-	16677
one OECac rat	16677
2 months postlesion -LRB- C -RRB-	16694
2 months postlesion	16694
C	16715
one OECdl rat at 3 months -LRB- D -RRB-	16725
one OECdl rat	16725
3 months -LRB- D -RRB-	16742
3 months	16742
D	16752
9 months following injury in rats of group OECac -LRB- E -RRB- and group OECdl -LRB- F -RRB-	16763
9 months	16763
injury in rats of group OECac -LRB- E -RRB- and group OECdl -LRB- F -RRB-	16782
injury	16782
rats of group OECac -LRB- E -RRB- and group OECdl -LRB- F -RRB-	16792
rats	16792
group OECac -LRB- E -RRB- and group OECdl -LRB- F -RRB-	16800
group OECac	16800
E	16813
group OECdl	16820
F	16833
Plot graphs	16837
the evolution of the amplitude -LRB- G -RRB- and the latency -LRB- H -RRB- of MEPs	16854
the evolution	16854
the amplitude -LRB- G -RRB- and the latency -LRB- H -RRB-	16871
the amplitude	16871
G	16886
the latency	16893
H	16906
MEPs	16912
Fig. 2 .	16919
Fig.	16919
2	16924
Representative electrophysiological recordings of M - and H-waves	16927
Representative electrophysiological recordings	16927
M	16977
stimulation of the sciatic nerve in intact and spinal cord transected animals	17002
stimulation	17002
the sciatic nerve in intact and spinal cord transected animals	17017
the sciatic nerve	17017
intact and spinal cord transected animals	17038
spinal cord	17049
the increase of the H-wave amplitude in injured rats , more marked	17086
the increase	17086
the H-wave amplitude in injured rats	17102
the H-wave amplitude	17102
injured rats	17126
DM-injected groups	17155
OEC-transplanted groups -LRB- A -RRB-	17182
OEC-transplanted groups	17182
A	17207
Plot showing the evolution of the H/M amplitude ratio over time -LRB- B -RRB- .	17211
Plot	17211
the evolution of the H/M amplitude ratio over time -LRB- B -RRB-	17224
the evolution	17224
the H/M amplitude ratio over time -LRB- B -RRB-	17241
the H/M amplitude ratio	17241
time -LRB- B -RRB-	17270
time	17270
B	17276
Plots of the BBB score over time after spinal cord transection for all the rats in each experimental group -LRB- C -RRB- , and for the rats that recovered versus the rats that did not recover MEPs in OECac and OECdl groups -LRB- D -RRB- .	17280
Plots	17280
the BBB score	17289
time	17308
spinal cord transection for all the rats in each experimental group -LRB- C -RRB-	17319
spinal cord transection	17319
all the rats in each experimental group -LRB- C -RRB-	17347
all the rats	17347
each experimental group -LRB- C -RRB-	17363
each experimental group	17363
C	17388
the rats that recovered versus the rats that did not recover MEPs in OECac and OECdl groups -LRB- D -RRB-	17400
the rats	17400
the rats that did not recover MEPs in OECac and OECdl groups	17431
the rats	17431
MEPs	17461
OECac and OECdl groups	17469
D	17493
P values	17497
P <	17508
P	17508
<	17510
0.05 , **	17512
0.05	17512
0.01 compared to group DMac ; # P < 0.05 , ## P < 0.01 compared to group DMdl ; $ P < 0.05 compared to group OECdl	17524
0.01	17524
group DMac ; # P < 0.05 , ## P < 0.01 compared to group DMdl ; $ P < 0.05 compared to group OECdl	17541
group DMac	17541
# P < 0.05 , ## P < 0.01 compared to group DMdl ; $ P < 0.05 compared to group OECdl	17553
# P < 0.05 , ## P < 0.01 compared to group DMdl ; $ P <	17553
# P < 0.05 , ## P < 0.01 compared to group DMdl	17553
# P <	17553
0.05 , ## P <	17558
0.05	17558
## P	17564
0.01 compared to group DMdl	17570
0.01	17570
group DMdl	17587
$ P <	17599
$ P	17599
<	17602
0.05 compared to group OECdl	17604
0.05	17604
group OECdl	17621
Fig. 3 .	17635
Fig.	17635
3	17640
Representative macroscopic images of completely	17643
Representative macroscopic images	17643
spinal cords	17702
9.5 months after injury	17718
9.5 months	17718
injury	17735
DMac -LRB- A -RRB- , DMdl -LRB- B -RRB- , OECac -LRB- C -RRB- , and OECdl groups -LRB- D -RRB-	17747
DMac -LRB- A -RRB-	17747
DMac	17747
A	17753
DMdl -LRB- B -RRB-	17757
DMdl	17757
B	17763
OECac -LRB- C -RRB-	17767
OECac	17767
C	17774
OECdl groups -LRB- D -RRB-	17782
OECdl groups	17782
D	17796
Arrows	17800
the transection site	17816
cranial	17838
the left	17852
DM groups -LRB- A , B -RRB-	17875
DM groups	17875
A , B	17886
A	17886
B	17889
there	17893
a translucent tissue with a dark background at the site of transection	17902
a translucent tissue	17902
a dark background at the site of transection	17928
a dark background	17928
the site of transection	17949
the site	17949
transection	17961
contrast	17977
spinal cords from OEC groups -LRB- C , D -RRB-	17990
spinal cords	17990
OEC groups -LRB- C , D -RRB-	18008
OEC groups	18008
the site of transection	18027
the site	18027
transection	18039
a whitish tissue	18065
all the images	18087
cranial	18103
the left and caudal at the right	18117
the left and caudal	18117
the right	18140
dorsal	18151
the top and ventral	18164
the bottom of the image	18187
the bottom	18187
the image	18201
Scale	18212
5 mm	18224
Fig. 4 .	18231
Fig.	18231
4	18236
Microscopic image of a transected spinal cord	18239
Microscopic image	18239
a transected spinal cord	18260
GFAP showing absence of GFAP-positive tissue at the transection site	18307
GFAP	18307
absence of GFAP-positive tissue	18320
absence	18320
GFAP-positive tissue	18331
the transection site	18355
GFAP labeling	18391
the surrounding cord	18412
parenchyma -LRB- A ; same orientation as in Fig. 3 -RRB-	18433
parenchyma	18433
A ; same orientation as in Fig. 3	18445
A	18445
same orientation as in Fig. 3	18448
same orientation as	18448
Fig. 3	18471
High-magnification image from the epicenter lesion of the same spinal cord showing the presence of GAP-43-immunoreactive axons within the transection site -LRB- B -RRB- .	18480
High-magnification image from the epicenter lesion of the same spinal cord	18480
High-magnification image	18480
the epicenter lesion of the same spinal cord	18510
the epicenter lesion	18510
the same spinal cord	18534
the presence of GAP-43-immunoreactive axons	18563
the presence	18563
GAP-43-immunoreactive axons	18579
the transection site -LRB- B -RRB-	18614
the transection site	18614
B	18636
Histogram graphs of the degree of immunoreactivity against NF200 -LRB- C -RRB- , GAP-43 -LRB- D -RRB- , and CGRP -LRB- E -RRB- at cranial , epicenter , and caudal regions of the injured spinal cords .	18640
Histogram graphs	18640
the degree of immunoreactivity	18660
the degree	18660
immunoreactivity	18674
NF200 -LRB- C -RRB- , GAP-43 -LRB- D -RRB- , and CGRP -LRB- E -RRB-	18699
NF200 -LRB- C -RRB-	18699
NF200	18699
C	18706
GAP-43 -LRB- D -RRB-	18710
GAP-43	18710
D	18718
CGRP -LRB- E -RRB-	18726
CGRP	18726
E	18732
cranial , epicenter , and caudal regions of the injured spinal cords	18738
cranial	18738
epicenter	18747
caudal regions of the injured spinal cords	18762
caudal regions	18762
the injured spinal cords	18780
Spinal cord section of one OECactransplanted rat showing CGRP-positive axons into the dorsal funiculi at the cranial stump edge -LRB- F -RRB- .	18806
Spinal cord section	18806
one OECactransplanted rat showing CGRP-positive axons into the dorsal funiculi at the cranial stump edge -LRB- F -RRB-	18829
one OECactransplanted rat	18829
CGRP-positive axons	18863
the dorsal funiculi at the cranial stump edge -LRB- F -RRB-	18888
the dorsal funiculi	18888
the cranial stump edge -LRB- F -RRB-	18911
the cranial stump edge	18911
F	18935
P <	18940
P	18940
<	18942
0.05	18944
P < 0.01 , *** P < 0.001 compared to group DMac ; # P < 0.05 , ## P < 0.01 , ### P < 0.001 compared to group DMdl	18952
P	18952
< 0.01 , *** P <	18954
< 0.01	18954
<	18954
0.01	18956
*** P	18962
0.001 compared to group DMac ; # P < 0.05	18969
0.001 compared to group DMac	18969
0.001	18969
group DMac	18987
# P < 0.05	18999
# P <	18999
0.05	19004
## P <	19010
0.01 , ### P <	19016
0.01	19016
### P	19022
0.001 compared to group DMdl	19029
0.001	19029
group DMdl	19047
Scale bar	19059
1000 µm in panel A , 150 µm in panel B , and 100 µm in panel E. Fig. 5	19076
1000 µm in panel A	19076
1000 µm	19076
panel A	19087
150 µm in panel B	19096
150 µm	19096
panel B	19106
100 µm in panel E. Fig. 5	19119
100 µm	19119
panel E. Fig. 5	19129
Histogram graph of the degree of reactivity of BDA , serotonin , and DhOH-positive axons at cranial , epicenter , and caudal regions of the transected spinal cord -LRB- A -RRB- .	19147
Histogram graph	19147
the degree of reactivity	19166
the degree	19166
reactivity	19180
BDA , serotonin , and DhOH-positive axons	19194
BDA	19194
serotonin	19199
DhOH-positive axons	19214
cranial , epicenter , and caudal regions of the transected spinal cord -LRB- A -RRB-	19237
cranial	19237
epicenter	19246
caudal regions of the transected spinal cord -LRB- A -RRB-	19261
caudal regions	19261
the transected spinal cord -LRB- A -RRB-	19279
the transected spinal cord	19279
A	19307
Micrographs of corticospinal -LRB- B -RRB- , raphespinal -LRB- C -RRB- , and coerulospinal -LRB- D -RRB-	19311
Micrographs	19311
corticospinal -LRB- B -RRB- , raphespinal -LRB- C -RRB- , and coerulospinal -LRB- D -RRB-	19326
corticospinal -LRB- B -RRB-	19326
raphespinal -LRB- C -RRB-	19345
coerulospinal	19366
D	19381
axons	19396
the transection site -LRB- arrows -RRB- of the spinal cord of an OECac rat	19409
the transection site -LRB- arrows -RRB-	19409
the transection site	19409
arrows	19431
the spinal cord of an OECac rat	19442
the spinal cord	19442
an OECac rat	19461
Micrographs of corticospinal -LRB- E , H -RRB- , raphespinal -LRB- F , I -RRB- , and coerulospinal -LRB- G , J -RRB-	19475
Micrographs	19475
corticospinal -LRB- E , H -RRB- , raphespinal -LRB- F , I -RRB- , and coerulospinal -LRB- G , J -RRB-	19490
corticospinal -LRB- E , H -RRB-	19490
corticospinal	19490
E , H	19505
E	19505
H	19508
raphespinal -LRB- F , I -RRB-	19512
raphespinal	19512
F	19525
I	19528
coerulospinal -LRB- G , J -RRB-	19536
coerulospinal	19536
axons observed at T11 growing through the white -LRB- E -- G -RRB- and gray -LRB- H -- J -RRB- matter -LRB- arrows -RRB- in a rat of group OECac	19569
axons	19569
T11 growing through the white -LRB- E -- G -RRB- and gray -LRB- H -- J -RRB- matter -LRB- arrows -RRB- in a rat of group OECac	19587
T11	19587
the white -LRB- E -- G -RRB- and gray -LRB- H -- J -RRB- matter -LRB- arrows -RRB-	19607
the white -LRB- E -- G -RRB- and gray -LRB- H -- J -RRB- matter	19607
E -- G	19618
E	19618
G	19620
H -- J	19633
H	19633
J	19636
arrows	19647
a rat of group OECac	19658
a rat	19658
group OECac	19667
all the images	19684
cranial	19700
the left and caudal at the right	19714
the left and caudal	19714
the right	19737
dorsal	19748
the top and ventral	19761
the bottom of the image	19784
the bottom	19784
the image	19798
P <	19810
P	19810
<	19812
0.05	19814
P	19822
< 0.01 compared to group DMac ; # P < 0.05 , ## P < 0.01 compared to group DMdl , $ P < 0.05 compared to group OECdl	19824
<	19824
0.01 compared to group DMac ; # P < 0.05 , ## P <	19826
0.01	19826
group DMac ; # P < 0.05 , ## P <	19843
group DMac ; # P < 0.05	19843
group DMac	19843
# P < 0.05	19855
# P <	19855
0.05	19860
## P	19866
0.01 compared to group DMdl	19872
0.01	19872
group DMdl	19889
$ P < 0.05	19901
P	19902
0.05	19906
group OECdl	19923
Scale	19936
100 µm	19948
Fig. 6 .	19957
Fig.	19957
6	19962
Micrographs of corticospinal -LRB- A -RRB- , raphespinal -LRB- B -RRB- , and coerulospinal -LRB- C -RRB- fibers -LRB- in red -RRB- close to the lumbar motoneurons -LRB- immunolabeled against ChAT , in green ; arrows -RRB- .	19965
Micrographs of corticospinal -LRB- A -RRB- , raphespinal -LRB- B -RRB- , and coerulospinal -LRB- C -RRB- fibers -LRB- in red -RRB-	19965
Micrographs	19965
corticospinal -LRB- A -RRB- , raphespinal -LRB- B -RRB- , and coerulospinal -LRB- C -RRB- fibers	19980
A	19995
B	20012
C	20035
the lumbar motoneurons -LRB- immunolabeled against ChAT , in green ; arrows -RRB-	20063
the lumbar motoneurons	20063
ChAT	20109
green ; arrows	20118
green	20118
arrows	20125
some regenerated axons	20144
close contact	20177
ChAT-immunoreactive motoneurons -LRB- insert -RRB-	20196
ChAT-immunoreactive motoneurons	20196
insert	20229
High-power magnification of NG2-immunoreactive cells -LRB- D -RRB- and GAP-43-positive axons -LRB- E -RRB- within the lesion epicenter .	20238
High-power magnification	20238
NG2-immunoreactive cells -LRB- D -RRB- and GAP-43-positive axons -LRB- E -RRB-	20266
NG2-immunoreactive cells	20266
D	20292
GAP-43-positive axons	20299
E	20322
the lesion epicenter	20332
Double staining	20354
GAP-43-labeled profiles	20381
their growing orientation	20413
NG2-immunoreactive cells -LRB- F -RRB-	20460
NG2-immunoreactive cells	20460
F	20486
Scale	20490
100 µm	20502
Fig. 7 .	20511
Fig.	20511
7	20516
Histogram of the degree of immunoreactivity against NG2 -LRB- A -RRB- and GFAP -LRB- B -RRB- at 9.5 months following injury in all experimental groups .	20519
Histogram	20519
the degree	20532
immunoreactivity	20546
NG2 -LRB- A -RRB- and GFAP -LRB- B -RRB-	20571
NG2	20571
A	20576
GFAP	20583
B	20589
9.5 months	20595
injury in all experimental groups	20616
injury	20616
all experimental groups	20626
Representative high-power magnification images of reactive astrocytes from DMac -LRB- C -RRB- , DMdl -LRB- D -RRB- , OECac -LRB- E -RRB- , and OECdl -LRB- F -RRB- groups .	20651
Representative	20651
high-power magnification images of reactive astrocytes from DMac -LRB- C -RRB- , DMdl -LRB- D -RRB- , OECac -LRB- E -RRB- , and OECdl -LRB- F -RRB- groups	20666
high-power magnification images of reactive astrocytes from DMac -LRB- C -RRB-	20666
high-power magnification images	20666
reactive astrocytes from DMac	20701
reactive astrocytes	20701
DMac	20726
C	20732
DMdl -LRB- D -RRB-	20736
DMdl	20736
D	20742
OECac -LRB- E -RRB-	20746
OECac	20746
E	20753
OECdl -LRB- F -RRB- groups	20761
OECdl	20761
F	20768
groups	20771
Astrocytes from OEC-transplanted rats , especially from group OECac ,	20779
Astrocytes from OEC-transplanted rats	20779
Astrocytes	20779
OEC-transplanted rats	20795
group OECac	20834
lesser hyperthophic morphology with thinner processes	20852
lesser hyperthophic morphology	20852
thinner processes	20888
a more aligned network	20916
DM-injected animals	20947
P <	20969
P	20969
<	20971
0.05	20973
P	20981
< 0.01 , *** P < 0.001 compared to group DMac ; # P < 0.05 , ## P < 0.01 , ### P < 0.001 compared to group DMdl ; $ $ P < 0.01 compared to group OECdl	20983
< 0.01 , *** P < 0.001 compared to group DMac ; # P < 0.05 , ## P < 0.01 , ### P < 0.001 compared to group DMdl ; $ $ P < 0.01	20983
<	20983
0.01 , *** P <	20985
0.01	20985
*** P	20991
0.001 compared to group DMac ; # P < 0.05 , ## P < 0.01 , ### P < 0.001 compared to group DMdl ; $ $ P < 0.01	20998
0.001 compared to group DMac	20998
0.001	20998
group DMac	21016
# P < 0.05 , ## P < 0.01 , ### P < 0.001 compared to group DMdl	21028
# P <	21028
0.05 , ## P < 0.01 , ### P <	21033
0.05 , ## P < 0.01 ,	21033
0.05	21033
## P < 0.01	21039
## P <	21039
0.01	21045
### P	21051
0.001 compared to group DMdl	21058
0.001	21058
group DMdl	21076
$ $ P < 0.01	21088
$ $ P <	21088
0.01	21094
group OECdl	21111
Scale	21124
50 µm	21136
All animals	21144
injury	21175
2 animals of group OECdl and 1 rat of group DMdl	21187
2 animals of group OECdl	21187
2 animals	21187
group OECdl	21200
1 rat of group DMdl	21216
1 rat	21216
group DMdl	21225
the second surgery for delayed transplantation	21248
the second surgery	21248
delayed transplantation	21271
There	21296
a loss of about 30 -- 40 % in the animals ' body weight	21306
a loss of about 30	21306
a loss	21306
30	21322
40 % in the animals ' body weight	21325
40 %	21325
the animals ' body weight	21332
the animals '	21332
the first week after spinal cord transection	21364
the first week	21364
spinal cord transection	21385
rats	21422
weight reaching values at 9 months of 124 ± 6 % , 117 ± 9 % , 138 ± 9 % , and 130 ± 6 % with respect to preoperative weight in groups DMac , DMdl , OECac , and OECdl , respectively	21440
weight	21440
values	21456
9 months of 124 ± 6 % , 117 ± 9 % , 138 ± 9 % , and 130 ± 6 %	21466
9 months	21466
124 ± 6 % , 117 ± 9 % , 138 ± 9 % , and 130 ± 6 %	21478
124 ± 6 %	21478
124 ±	21478
6 %	21484
117 ± 9 %	21488
117	21488
9 %	21494
138 ± 9 %	21498
138	21498
9 %	21504
130 ± 6 %	21512
130	21512
6 %	21518
respect	21526
preoperative weight in groups DMac , DMdl , OECac , and OECdl , respectively	21537
preoperative weight	21537
groups DMac , DMdl , OECac , and OECdl , respectively	21560
groups DMac , DMdl , OECac , and OECdl	21560
groups	21560
DMac , DMdl , OECac , and OECdl	21567
One or two rats from each group	21611
One or two rats	21611
each group	21632
due to breast tumors after 6 months follow-up	21667
breast tumors after 6 months	21674
breast tumors	21674
6 months	21694
The numbers of surviving animals at the end of the study	21714
The numbers	21714
surviving animals at the end of the study	21729
surviving animals	21729
the end of the study	21750
the end	21750
the study	21761
7 , 5 , 6 , and 5 in DMac , DMdl , OECac , and OECdl groups ,	21776
7	21776
5 , 6 , and 5 in DMac , DMdl , OECac , and OECdl groups	21779
5 , 6 , and 5	21779
DMac , DMdl , OECac , and OECdl groups	21794
Electrophysiological results MEPs with a latency of about 6 ms and amplitude of 8 -- 10 mV	21845
Electrophysiological results MEPs	21845
a latency of about 6 ms and amplitude of 8 -- 10 mV	21884
a latency	21884
6 ms and amplitude of 8 -- 10 mV	21903
6 ms	21903
amplitude of 8	21912
amplitude	21912
8	21925
10 mV	21927
the gastrocnemius muscle of intact animals	21952
the gastrocnemius muscle	21952
intact animals	21980
Fig. 1A	21996
Table	22009
spinal cord transection	22025
MEPs	22050
the 9 months in DM-injected animals	22097
the 9 months	22097
DM-injected animals	22113
complete interruption of spinal motor pathways -LRB- Fig. 1B -RRB-	22145
complete interruption	22145
spinal motor pathways -LRB- Fig. 1B -RRB-	22170
spinal motor pathways	22170
Fig. 1B	22193
contrast	22206
4 of 6 animals of group OECac	22216
4	22216
6 animals of group OECac	22221
6 animals	22221
group OECac	22234
recovery of MEPs starting by 2 -- 3 months and 4 of 5 animals of group OECdl by 3 --	22253
recovery of MEPs starting by 2	22253
recovery	22253
MEPs starting by 2	22265
MEPs	22265
2	22282
3 months and 4 of 5 animals of group OECdl by 3	22284
3 months	22284
4 of 5 animals of group OECdl by 3	22297
4	22297
5 animals of group OECdl by 3	22302
5 animals	22302
group OECdl by 3	22315
group OECdl	22315
3	22330
4 months	22332
axonal regeneration and functional spinal reconnection -LRB- Figs. 1C -- D ; Table 1 -RRB-	22353
axonal regeneration and functional spinal reconnection	22353
Figs. 1C	22409
D ; Table 1	22418
D	22418
Table 1	22421
The proportions of rats that recovered MEPs	22431
The proportions	22431
rats that recovered MEPs	22450
rats	22450
MEPs	22470
OECac and OECdl groups	22516
both	22544
P < 0.05 , chi-square test	22563
P	22563
< 0.05 , chi-square test	22565
<	22565
0.05 , chi-square test	22567
0.05	22567
chi-square test	22573
DM groups	22598
intact animals	22621
the first MEPs recorded in regenerated animals	22637
the first MEPs	22637
regenerated animals	22664
multiple waves of low amplitude and long latency	22697
multiple waves	22697
low amplitude and long latency	22715
low amplitude	22715
long latency	22733
time	22753
MEPs	22759
amplitude	22777
latency	22801
single or polyphasic waves -LRB- Figs. 1E -- F -RRB-	22828
single or polyphasic waves	22828
Figs. 1E -- F	22856
Figs. 1E	22856
F	22865
animals that received an acute OEC graft	22884
animals	22884
an acute OEC graft	22906
MEPs of higher amplitude and shorter latency	22940
MEPs	22940
higher amplitude and shorter latency	22948
higher amplitude	22948
shorter latency	22969
those with a delayed transplant -LRB- Figs. 1G -- H -RRB-	22990
those	22990
a delayed transplant -LRB- Figs. 1G -- H -RRB-	23001
a delayed transplant	23001
Figs. 1G -- H	23023
Figs. 1G	23023
H	23032
9 months	23039
the mean amplitude of MEPs	23049
the mean amplitude	23049
MEPs	23071
0.72 ± 0.41 mV	23080
0.72	23080
0.41 mV	23087
group OECac -LRB- n = 4 -RRB- and 0.28 ± 0.11 mV	23098
group OECac -LRB- n = 4 -RRB-	23098
group OECac	23098
n	23111
4	23115
0.28 ± 0.11 mV	23122
0.28	23122
0.11 mV	23129
group OECdl -LRB- n = 4 -RRB- -LRB- Table 1 -RRB-	23140
group OECdl -LRB- n = 4 -RRB-	23140
group OECdl	23140
n	23153
4	23157
Table 1	23161
the mean latency	23179
16.0 ± 2.1 ms and 17.6 ± 1.2 ms	23200
16.0 ± 2.1 ms	23200
16.0 ±	23200
2.1 ms	23207
17.6 ± 1.2 ms	23218
17.6 ±	23218
1.2 ms	23225
injury	23254
the amplitude of the M-wave in plantar muscles	23262
the amplitude	23262
the M-wave in plantar muscles	23279
the M-wave	23279
plantar muscles	23293
7 -- 9 mV	23319
7	23319
9 mV	23321
the H-wave	23338
250 -- 600 AV	23349
250	23349
600 AV	23353
injury	23367
the M-wave amplitude	23375
80 -- 90 % of preoperative values	23420
80	23420
90 % of preoperative values	23423
90 %	23423
preoperative values	23430
the amplitude of the H-wave	23459
the amplitude	23459
the H-wave	23476
all injured rats -LRB- Table 1 -RRB-	23500
all injured rats	23500
Table 1	23518
The H/M ratio	23528
the 9-month follow-up in DM-injected animals	23573
the 9-month follow-up	23573
DM-injected animals	23598
OEC-transplanted animals	23630
the H/M ratio increased during the first 3 -- 4 months but remained stable afterwards	23655
the H/M ratio	23655
the first 3	23686
4 months	23698
Figs. 2A , B	23739
Figs. 2A	23739
B	23748
The facilitation of the H-reflex	23752
The facilitation	23752
the H-reflex	23772
group OECac	23814
all the follow-up	23833
9 months	23855
the H/M ratio	23865
717 ± 94 % , 679 ± 100 % , 335 ± 70 % , and 420 ± 50 %	23888
717 ± 94 %	23888
717	23888
94 %	23894
679 ± 100 %	23899
679 ±	23899
335 ± 70 %	23911
335	23911
70 %	23917
420 ± 50 %	23926
420	23926
50 %	23932
respect	23941
preoperative values in DMac , DMdl , OECac , and OECdl groups , respectively -LRB- Figs. 2A , B -RRB-	23952
preoperative values in DMac , DMdl , OECac , and OECdl groups , respectively	23952
preoperative values in DMac , DMdl , OECac , and OECdl groups	23952
preoperative values	23952
DMac , DMdl , OECac , and OECdl groups	23975
Figs. 2A , B	24026
Figs. 2A	24026
B	24035
OEC-transplanted rats in comparison	24068
OEC-transplanted rats	24068
comparison	24093
DM-injected rats	24109
Neurological outcome	24127
injury	24155
all the animals	24163
normal locomotor activity	24186
21	24222
the BBB scale	24228
7 days postinjury	24246
there	24265
complete absence of hindlimb movements in all the rats -LRB- Fig. 2C -RRB-	24275
complete absence	24275
hindlimb movements in all the rats -LRB- Fig. 2C -RRB-	24295
hindlimb movements	24295
all the rats -LRB- Fig. 2C -RRB-	24317
all the rats	24317
Fig. 2C	24331
follow-up	24348
rats of DMac and DMdl groups	24359
rats	24359
DMac and DMdl groups	24367
no hindlimb movement -LRB- score 0 -RRB- , slight movements of one or two joints , or extensive movement of one joint -LRB- scores 1 or 2 -RRB-	24402
no hindlimb movement -LRB- score 0 -RRB-	24402
no hindlimb movement	24402
score 0	24424
slight movements of one or two joints	24434
slight movements	24434
one or two joints	24454
extensive movement of one joint -LRB- scores 1 or 2 -RRB-	24476
extensive movement of one joint	24476
extensive movement	24476
one joint	24498
scores 1 or 2	24509
contrast	24528
acutely OEC-transplanted animals	24538
hindlimb motor skills	24595
2 to 3 months	24622
the end of the study	24639
the end	24639
the study	24650
a final average BBB score of 4.2 ± 0.7 points	24670
a final average BBB score	24670
4.2 ± 0.7 points	24699
4.2 ±	24699
0.7 points	24705
Rats with delayed OEC grafts	24717
Rats	24717
delayed OEC grafts	24727
hindlimb movements	24756
3 to 4 months	24780
a final average score of 3.7 ± 0.4 points -LRB- Fig. 2C -RRB-	24804
a final average score	24804
3.7 ± 0.4 points -LRB- Fig. 2C -RRB-	24829
3.7 ± 0.4 points	24829
Fig. 2C	24847
OEC-transplanted rats that did not show MEPs recovery	24857
OEC-transplanted rats	24857
MEPs recovery	24897
BBB values similar to those of DM-injected animals	24915
BBB values	24915
those of DM-injected animals	24937
those	24937
DM-injected animals	24946
OEC-transplanted rats that recovered MEPs	24975
OEC-transplanted rats	24975
MEPs	25012
higher values	25024
between 4 and 7 points -LRB- average 5.3 ± 0.5 for the 4 rats of group OECac , and 4.1 ± 0.3 for the 4 rats of group OECdl -RRB- -LRB- Fig. 2D -RRB-	25046
between 4 and 7 points -LRB- average 5.3 ± 0.5 for the 4 rats of group OECac , and 4.1 ± 0.3 for the 4 rats of group OECdl -RRB-	25046
between 4 and 7 points	25046
average 5.3 ± 0.5 for the 4 rats of group OECac , and 4.1 ± 0.3 for the 4 rats of group OECdl	25070
average 5.3 ± 0.5	25070
average 5.3	25070
0.5	25084
the 4 rats of group OECac , and 4.1 ± 0.3 for the 4 rats of group OECdl	25092
the 4 rats of group OECac	25092
the 4 rats	25092
group OECac	25106
4.1 ± 0.3 for the 4 rats of group OECdl	25123
4.1 ±	25123
0.3 for the 4 rats of group OECdl	25129
0.3	25129
the 4 rats of group OECdl	25137
the 4 rats	25137
group OECdl	25151
Fig. 2D	25165
The BBB score	25175
the amplitude -LRB- r = 0.81 , P < 0.001 -RRB-	25223
the amplitude	25223
r = 0.81 , P < 0.001	25238
r	25238
= 0.81 , P < 0.001	25240
= 0.81 , P <	25240
0.81 , P	25242
0.81	25242
P	25248
0.001	25252
the latency of MEPs -LRB- r = -0.44 , P < 0.05 -RRB-	25268
the latency	25268
MEPs -LRB- r = -0.44 , P < 0.05 -RRB-	25283
MEPs	25283
r = -0.44 , P < 0.05	25289
r	25289
= -0.44 , P < 0.05	25291
= -0.44 , P <	25291
-0.44 , P	25293
-0.44	25293
P	25300
0.05	25304
the climbing test	25314
all animals	25333
the highest angle -LRB- 90 ° -RRB-	25363
the highest angle	25363
90 °	25382
injury	25394
One week following spinal cord transection , none of the rats	25402
One week	25402
spinal cord transection , none of the rats	25421
spinal cord transection	25421
none of the rats	25446
none	25446
the rats	25454
the lowest inclination angle -LRB- 45 ° -RRB-	25472
the lowest inclination angle	25472
45 °	25502
1 month to the end of the follow-up	25513
1 month	25513
the end of the follow-up	25524
the end	25524
the follow-up	25535
all the rats	25550
the platform	25572
inclinations of 45 ° and 60 °	25590
inclinations	25590
45 ° and 60 °	25606
45 °	25606
60 °	25614
some animals from all the experimental groups	25623
some animals	25623
all the experimental groups	25641
the inclined grid at 90 ° angle	25687
the inclined grid	25687
90 ° angle	25708
animals that achieved the maximal level	25734
animals	25734
the maximal level	25756
the same	25783
the different monthly tests	25795
Axonal regeneration	25824
final dissection	25851
the transection site	25869
the presence of an opaque tissue binding rostral and caudal stumps	25908
the presence	25908
an opaque tissue binding rostral and caudal stumps	25924
an opaque tissue binding rostral	25924
caudal stumps	25961
animals of DM groups -LRB- Figs. 3A -- B -RRB-	25978
animals	25978
DM groups -LRB- Figs. 3A -- B -RRB-	25989
DM groups	25989
Figs. 3A -- B	26000
Figs. 3A	26000
B	26009
contrast	26016
animals of OEC groups	26029
animals	26029
OEC groups	26040
the transection site	26052
the presence of a white tissue that bridged both cord stumps -LRB- Figs. 3C -- D -RRB-	26080
the presence	26080
a white tissue that bridged both cord stumps -LRB- Figs. 3C -- D -RRB-	26096
a white tissue	26096
both cord stumps	26124
Figs. 3C -- D	26142
Figs. 3C	26142
D	26151
the scar tissue	26172
meningeal origin	26209
the two stumps where reactive gliosis and cavitation were prominent -LRB- Fig. 4A -RRB-	26258
the two stumps	26258
reactive gliosis and cavitation	26279
reactive gliosis	26279
cavitation	26300
Fig. 4A	26327
9 months postinjury	26340
DM-injected animals	26364
many NF-200 - and GAP-43-immunoreactive axons	26385
many NF-200	26385
GAP-43-immunoreactive axons	26402
the cranial and caudal stumps	26444
considerably less labeled profiles	26479
the central scar	26531
most of them	26552
most	26552
them	26560
the scar interface -LRB- Fig. 4B -RRB-	26576
the scar interface	26576
Fig. 4B	26596
contrast	26609
OEC-transplanted animals	26622
NF200 and GAP-43 labeled axons	26648
NF200 and GAP-43	26648
axons	26673
the lesion site	26703
group OECac -LRB- Figs. 4C -- D -RRB-	26743
group OECac	26743
Figs. 4C -- D	26756
Figs. 4C	26756
D	26765
Sensory fibers , identified by immunolabeling against CGRP ,	26769
Sensory fibers	26769
immunolabeling against CGRP	26799
immunolabeling	26799
CGRP	26822
the dorsal aspect of the caudal stump in all experimental groups	26844
the dorsal aspect	26844
the caudal stump in all experimental groups	26865
the caudal stump	26865
all experimental groups	26885
the degree of immunoreactivity	26919
the degree	26919
immunoreactivity	26933
groups OECac and OECdl in comparison	26978
groups OECac and OECdl	26978
comparison	27004
groups DMac and DMdl -LRB- P < 0.01 -RRB- -LRB- Fig. 4E -RRB-	27020
groups DMac and DMdl -LRB- P < 0.01 -RRB-	27020
groups DMac and DMdl	27020
P < 0.01	27043
P	27043
< 0.01	27045
<	27045
0.01	27047
Fig. 4E	27054
Some CGRP-positive axons	27064
the epicenter of the lesion	27097
the epicenter	27097
the lesion	27114
they	27131
a dorsoventral orientation	27144
a few of them	27176
a few	27176
them	27185
the cranial stump -LRB- Fig. 4F -RRB-	27198
the cranial stump	27198
Fig. 4F	27217
Significantly higher immunoreactivity for CGRP	27227
Significantly higher immunoreactivity	27227
CGRP	27269
the epicenter region	27291
the cranial stump in group OECac	27319
the cranial stump	27319
group OECac	27340
the other three groups -LRB- P < 0.001 -RRB- -LRB- Fig. 4E -RRB-	27360
the other three groups -LRB- P < 0.001 -RRB-	27360
the other three groups	27360
P < 0.001	27385
P	27385
< 0.001	27387
<	27387
0.001	27389
Fig. 4E	27397
regenerated descending motor axons , the corticospinal tract	27419
regenerated descending motor axons	27419
the corticospinal tract	27455
BDA	27509
raphespinal -LRB- serotoninergic -RRB- and coerulospinal -LRB- noradrenergic -RRB- tracts	27518
immunohistochemistry	27610
serotonin and DhOH	27635
the cranial stump	27672
corticospinal axons	27691
the dorsal columns and fewer axons	27739
the dorsal columns	27739
fewer axons	27762
the ventral funiculi	27777
Raphespinal and coerulospinal axons	27799
ventral and ventrolateral aspects of the spinal cord	27859
ventral and ventrolateral aspects	27859
the spinal cord	27896
all transected animals	27916
these fibers	27940
the epicenter region , where they changed in orientation and spread dorso-ventrally , growing through to outermost part of the spinal cord -LRB- Figs. 5B -- C -RRB-	27979
the epicenter region	27979
they	28007
orientation and spread	28023
outermost part of the spinal cord -LRB- Figs. 5B -- C -RRB-	28082
outermost part	28082
the spinal cord -LRB- Figs. 5B -- C -RRB-	28100
the spinal cord	28100
Figs. 5B -- C	28117
Figs. 5B	28117
C	28126
more labeled fibers	28145
the rostral	28181
epicenter sites in OEC	28197
epicenter sites	28197
OEC	28216
DMinjected animals -LRB- Fig. 5A -RRB-	28229
DMinjected animals	28229
Fig. 5A	28249
No descending fibers	28259
the caudal glial scar	28288
DM-injected animals	28313
one rat of group DMac	28352
one rat	28352
group DMac	28363
some scattered raphespinal and corticospinal axons	28375
some scattered raphespinal	28375
corticospinal axons	28406
1 mm	28443
the rostral edge of the caudal stump	28453
the rostral edge	28453
the caudal stump	28473
contrast	28494
long axonal regeneration	28504
animals	28550
an OEC transplant	28568
corticospinal , raphespinal , and coerulospinal fibers regrown until lumbar segments of the spinal cord	28592
corticospinal , raphespinal , and coerulospinal fibers	28592
lumbar segments of the spinal cord	28659
lumbar segments	28659
the spinal cord	28678
Descending fibers	28695
the caudal stump	28732
the gray matter	28770
the white matter -LRB- Figs. 5E -- J -RRB-	28798
the white matter	28798
Figs. 5E -- J	28816
Figs. 5E	28816
J	28825
the cord lumbar segments	28832
regenerated fibers	28858
the central gray matter -LRB- laminae X and VIII -RRB-	28898
the central gray matter	28898
laminae X and VIII	28923
laminae X	28923
VIII	28937
a few axons	28948
the ventral gray matter	28987
motoneurons -LRB- Figs. 6A -- C -RRB-	29033
motoneurons	29033
Figs. 6A -- C	29046
Figs. 6A	29046
C	29055
Significant correlations	29059
BBB score	29103
density of serotoninergic , noradrenergic and corticospinal fibers	29117
density	29117
serotoninergic , noradrenergic and corticospinal fibers	29128
the lesion edge -LRB- r = 0.93 , r = 0.95 , r = 0.87 , respectively , all P < 0.001 -RRB-	29193
the lesion edge	29193
r = 0.93 , r = 0.95 , r = 0.87 , respectively , all P < 0.001	29210
r	29210
0.93 , r = 0.95 , r = 0.87 , respectively , all P < 0.001	29214
0.93 , r = 0.95 , r = 0.87 , respectively	29214
0.93	29214
r = 0.95	29220
r	29220
0.95	29224
r = 0.87 , respectively	29230
r	29230
= 0.87	29232
all P < 0.001	29254
all P	29254
0.001	29262
the amplitude of MEPs and the density of fibers -LRB- r = 0.90 , r = 0.92 , r = 0.77 , respectively , all P < 0.001 -RRB-	29281
the amplitude	29281
MEPs and the density	29298
MEPs	29298
the density	29307
fibers	29322
r = 0.90 , r = 0.92 , r = 0.77 , respectively , all P < 0.001	29330
r	29330
0.90 , r = 0.92 , r = 0.77 , respectively , all P < 0.001	29334
0.90 , r = 0.92 , r = 0.77 , respectively	29334
0.90	29334
r = 0.92	29340
r	29340
r = 0.77 , respectively	29350
r	29350
= 0.77	29352
all P < 0.001	29374
all P	29374
0.001	29382
We	29390
transplanted OECs using immunostaining against p75NTR , as in previous studies -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. , 2003 ; Resnick et al. , 2003 ; Ruitenberg et al. , 2003 ; Takami et al. , 2002 -RRB-	29415
transplanted OECs	29415
immunostaining against p75NTR	29439
immunostaining	29439
p75NTR	29462
previous studies	29476
Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. , 2003 ; Resnick et al. , 2003 ; Ruitenberg et al. , 2003 ; Takami et al. , 2002	29494
Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. , 2003 ; Resnick et al. , 2003 ; Ruitenberg et al. , 2003 ; Takami et al. ,	29494
Garcı ' a-Alı ' as et al. , 2004	29494
Garcı ' a-Alı	29494
et al.	29509
2004	29517
Plant et al. , 2003	29523
Plant	29523
et al. , 2003	29529
et al.	29529
2003	29537
Resnick et al. , 2003	29543
Resnick	29543
et al. , 2003	29551
et al.	29551
2003	29559
Ruitenberg et al. , 2003 ; Takami et al. ,	29565
Ruitenberg	29565
et al. , 2003 ; Takami et al. ,	29576
et al.	29576
2003 ; Takami et al.	29584
2003	29584
Takami et al.	29590
Takami	29590
et al.	29597
2002	29605
no p75NTR-immunoreactive cells	29616
the spinal cord parenchyma of any transplanted animal after 9 months	29668
the spinal cord parenchyma	29668
any transplanted animal after 9 months	29698
any transplanted animal	29698
9 months	29728
GFAP and NG2 expression GFAP and NG2 stainings	29738
GFAP and NG2 expression GFAP	29738
NG2 stainings	29771
the nonpermissive environment for regeneration	29807
the nonpermissive environment	29807
regeneration	29841
spinal cord transection	29860
NG2 immunostaining	29885
meningeallike cells that followed a transverse orientation within the lesion epicenter -LRB- Fig. 6D -RRB-	29927
meningeallike cells	29927
a transverse orientation	29961
the lesion epicenter	29993
Fig. 6D	30015
Double staining against NG2 and GAP-43	30025
Double staining	30025
NG2 and GAP-43	30049
regenerating axons	30078
the NG2 barrier	30111
their original pathway	30139
NG2-immunoreactive cells -LRB- Figs. 6D -- F -RRB-	30172
NG2-immunoreactive cells	30172
Figs. 6D -- F	30198
Figs. 6D	30198
F	30207
NG2-positive cells with stellate morphology and non-immunoreactive for GFAP	30211
NG2-positive cells with stellate morphology	30211
NG2-positive cells	30211
stellate morphology	30235
non-immunoreactive for GFAP	30259
non-immunoreactive	30259
GFAP	30282
the lesion margins	30304
the spinal cord parenchyma	30339
acute OEC grafts	30383
decreased NG2 immunoreactivity in comparison with DM-injected animals within the lesion epicenter and in cranial and caudal stumps -LRB- Fig. 7A -RRB-	30412
decreased NG2 immunoreactivity	30412
comparison with DM-injected animals within the lesion epicenter and in cranial and caudal stumps -LRB- Fig. 7A -RRB-	30446
comparison	30446
DM-injected animals within the lesion epicenter	30462
DM-injected animals	30462
the lesion epicenter	30489
cranial and caudal stumps -LRB- Fig. 7A -RRB-	30517
cranial and caudal stumps	30517
Fig. 7A	30544
Delayed OEC grafts	30554
NG2 immunoreactivity	30590
The glial scar , surrounding the lesion epicenter ,	30637
The glial scar	30637
the lesion epicenter	30665
numerous hypertrophic interwoven GFAP-positive processes	30697
The density of GFAP-immunoreactive processes	30755
The density	30755
GFAP-immunoreactive processes	30770
the lesion margins	30822
the adjacent cord tissue	30848
the lesion site	30908
Astrocytes in samples of OECac rats	30925
Astrocytes	30925
samples of OECac rats	30939
samples	30939
OECac rats	30950
less hypertrophied morphology and thinner processes	30965
less hypertrophied morphology	30965
thinner processes	30999
a more aligned meshwork	31029
DM-injected animals	31070
Figs. 7C -- F	31091
Figs. 7C	31091
F	31100
group OECac	31120
signifi	31136
GFAP expression	31160
both cranial and caudal cord regions with respect	31179
both cranial and caudal cord regions	31179
respect	31221
both DM-injected groups	31232
group OECdl	31265
intermediate values -LRB- Fig. 7B -RRB-	31281
intermediate values	31281
Fig. 7B	31302
Discussion The results of the present work demonstrate that both acute and delayed OEC transplantation into the completely transected spinal cord of adult rats	31313
Discussion	31313
The results of the present work	31324
The results	31324
the present work	31339
both	31373
OEC transplantation	31396
the	31421
spinal cord of adult rats	31447
spinal cord	31447
adult rats	31462
long axonal regeneration and partial recovery of motor functions	31481
long axonal regeneration	31481
partial recovery of motor functions	31510
partial recovery	31510
motor functions	31530
spinal cord transection	31553
only rats that received an OEC transplant	31578
only rats	31578
an OEC transplant	31602
recovery of MEPs	31627
recovery	31627
MEPs	31639
no electrophysiological responses	31653
nontransplanted rats over the 9 months follow-up	31704
nontransplanted rats	31704
the 9 months follow-up	31730
parallel with MEP restitution	31757
parallel	31757
MEP restitution	31771
transplanted animals	31788
slight improvement of hindlimb motor function and significant reduction of lumbar Hreflex facilitation	31816
slight improvement of hindlimb motor function	31816
slight improvement	31816
hindlimb motor function	31838
significant reduction of lumbar Hreflex facilitation	31866
significant reduction	31866
lumbar Hreflex facilitation	31891
The histological results	31920
long axonal regeneration of corticospinal , raphespinal , and coerulospinal descending fibers and possible reconnection with lumbar motor nuclei	31952
long axonal regeneration	31952
corticospinal , raphespinal , and coerulospinal descending fibers and possible reconnection with lumbar motor nuclei	31980
corticospinal , raphespinal , and coerulospinal descending fibers	31980
possible reconnection with lumbar motor nuclei	32048
possible reconnection	32048
lumbar motor nuclei	32075
OEC transplanted rats	32103
higher immunoreactivity levels for NF-200 , GAP-43 , and CGRP , and lower for GFAP and NG2 immunoreactivity	32136
higher immunoreactivity levels	32136
NF-200 , GAP-43 , and CGRP , and lower for GFAP and NG2 immunoreactivity	32171
NF-200 , GAP-43 , and CGRP ,	32171
lower for GFAP and NG2 immunoreactivity	32201
lower	32201
GFAP and NG2 immunoreactivity	32211
OEC	32254
DMinjected animals	32267
neurological , electrophysiological , and histological results	32296
rats that received an acute OEC transplant than in those with 1 week delayed transplant	32381
rats	32381
an acute OEC transplant	32400
those with 1 week delayed transplant	32432
those	32432
1 week delayed transplant	32443
1 week	32443
transplant	32458
Functional recovery induced by OEC grafts OECs obtained from either olfactory bulb or olfactory mucosa	32470
Functional recovery	32470
OEC grafts OECs obtained from either olfactory bulb or olfactory mucosa	32501
OEC grafts OECs	32501
either olfactory bulb or olfactory mucosa	32531
olfactory bulb	32538
olfactory mucosa	32556
functional recovery and axonal regeneration	32603
functional recovery	32603
axonal regeneration	32627
spinal cord contusion -LRB- Plant et al. , 2003 -RRB- , crush injury -LRB- Ramer et al. , 2004a -RRB- , electrolytic injury -LRB- Keyvan-Fouladi et al. , 2003 ; Li et al. , 1998 -RRB- , photochemical injury -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Verdu ' et al. , 2003 -RRB- , and complete transection in rats -LRB- Lu et al. , 2001 , 2002 ; Ramo ' n-Cueto et al. , 2000 -RRB-	32653
spinal cord contusion -LRB- Plant et al. , 2003 -RRB- , crush injury -LRB- Ramer et al. , 2004a -RRB- , electrolytic injury -LRB- Keyvan-Fouladi et al. , 2003 ; Li et al. , 1998 -RRB- , photochemical injury -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Verdu ' et al. , 2003 -RRB- , and complete transection in rats	32653
spinal cord contusion -LRB- Plant et al. , 2003 -RRB-	32653
spinal cord contusion	32653
Plant	32676
et al. , 2003	32682
et al.	32682
2003	32690
crush injury -LRB- Ramer et al. , 2004a -RRB-	32697
crush injury	32697
Ramer	32711
et al. , 2004a	32717
et al.	32717
2004a	32725
electrolytic injury -LRB- Keyvan-Fouladi et al. , 2003 ; Li et al. , 1998 -RRB-	32733
electrolytic injury	32733
Keyvan-Fouladi	32754
et al. , 2003 ; Li et al. , 1998	32769
et al.	32769
2003 ; Li et al.	32777
2003	32777
Li et al.	32783
Li	32783
et al.	32786
1998	32794
photochemical injury -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Verdu ' et al. , 2003 -RRB-	32801
photochemical injury	32801
Garcı ' a-Alı ' as et al. , 2004 ; Verdu ' et al. , 2003	32823
Garcı ' a-Alı ' as et al. , 2004	32823
Garcı ' a-Alı	32823
et al.	32838
2004	32846
Verdu ' et al. , 2003	32852
Verdu '	32852
et al. , 2003	32859
et al.	32859
2003	32867
complete transection in rats	32878
complete transection	32878
rats	32902
Lu	32908
et al. , 2001 , 2002 ; Ramo ' n-Cueto et al. , 2000	32911
et al.	32911
2001 , 2002 ; Ramo ' n-Cueto et al.	32919
2001 , 2002	32919
2001	32919
2002	32925
Ramo ' n-Cueto et al.	32931
Ramo ' n-Cueto	32931
Ramo '	32931
et al.	32944
2000	32952
A key point after treatments to repair the injured spinal cord is whether functional recovery is due to axonal pathways that regenerate across the lesion or to changes in spinal circuits	32959
A key point	32959
treatments to repair the injured spinal cord	32977
the injured spinal cord	32998
functional recovery	33033
axonal pathways that regenerate across the lesion or to changes in spinal circuits	33063
axonal pathways	33063
the lesion	33102
changes in spinal circuits	33119
changes	33119
spinal circuits	33130
the lesion -LRB- Fouad and Pearson , 2004 -RRB-	33156
the lesion	33156
Fouad and Pearson , 2004	33168
Fouad	33168
Pearson , 2004	33178
Pearson	33178
2004	33187
rats with OEC transplants	33197
rats	33197
OEC transplants	33207
we	33224
descending fibers from motor cortex and brainstem	33238
descending fibers	33238
motor cortex and brainstem	33261
the lesion	33301
lumbar segments	33341
A novel finding of the present work	33358
A novel finding	33358
the present work	33377
spinal cord transection	33408
70 -- 80 % of OEC-transplanted rats	33433
70 -- 80 %	33433
70	33433
OEC-transplanted rats	33443
recovery of MEPs , but none of the control DM-injected rats	33472
recovery of MEPs	33472
recovery	33472
MEPs	33484
none of the control DM-injected rats	33494
none	33494
the control DM-injected rats	33502
MEPs	33532
electrical stimulation of cortical and brainstem motor neurons , which propagate impulses along the spinal cord to excite lumbar motoneurons -LRB- Konrad and Tacker , 1990 -RRB-	33552
electrical stimulation	33552
cortical and brainstem motor neurons , which propagate impulses along the spinal cord to excite lumbar motoneurons -LRB- Konrad and Tacker , 1990 -RRB-	33578
cortical and brainstem motor neurons	33578
impulses along the spinal cord	33632
impulses	33632
the spinal cord	33647
lumbar motoneurons -LRB- Konrad and Tacker , 1990 -RRB-	33673
lumbar motoneurons	33673
Konrad and Tacker	33693
1990	33712
spinal cord transection	33725
MEPs	33750
all descending tracts	33773
they	33814
time	33838
spontaneous axonal regeneration	33851
the non-transplanted spinal cord -LRB- Valero-Cabre ' et al. , 2004 -RRB-	33896
the non-transplanted spinal cord	33896
Valero-Cabre ' et al. , 2004	33930
Valero-Cabre '	33930
et al.	33944
2004	33952
recovery of electrophysiological responses observed after OEC transplantation	33970
recovery	33970
electrophysiological responses observed after OEC transplantation	33982
electrophysiological responses	33982
OEC transplantation	34028
regrowth and caudal functional reconnection of a number of supraspinal axons that crossed the lesion site	34067
regrowth	34067
caudal functional reconnection of a number of supraspinal axons that crossed the lesion site	34080
caudal functional reconnection	34080
a number of supraspinal axons	34114
a number	34114
supraspinal axons	34126
the lesion site	34157
OEC-grafted animals	34174
their locomotor behavior	34203
MEPs	34238
recovery of motor skills	34271
recovery	34271
motor skills	34283
descending control of hindlimb movements	34317
descending control	34317
hindlimb movements	34339
Ramo ' n-Cueto et al. -LRB- 2000 -RRB-	34359
Ramo ' n-Cueto et al.	34359
Ramo ' n-Cueto	34359
Ramo '	34359
et al.	34372
2000	34380
recovery of hindlimb function	34395
recovery	34395
hindlimb function	34407
the climbing test by acute OEC transplantation after complete spinal cord transection	34428
test	34441
acute OEC transplantation	34449
complete spinal cord	34481
the results shown in the present and other studies -LRB- Casas et al. , 2001 ; Valero-Cabre ' and Navarro , unpublished data -RRB-	34524
the results	34524
the present and other studies -LRB- Casas et al. , 2001 ; Valero-Cabre ' and Navarro , unpublished data -RRB-	34545
the present and other studies	34545
Casas	34576
et al. , 2001 ; Valero-Cabre ' and Navarro , unpublished data	34582
et al.	34582
2001 ; Valero-Cabre ' and Navarro	34590
2001	34590
Valero-Cabre ' and Navarro	34596
Valero-Cabre '	34596
Navarro	34614
unpublished data	34623
the climbing test	34655
some control-transected animals	34699
high scores , probably due to reflex rather than voluntary hindlimb movements	34740
high scores	34740
reflex rather than voluntary hindlimb movements	34769
reflex	34769
voluntary hindlimb movements	34788
contrast	34821
the improvement in the BBB score observed in OEC-transplanted animals	34831
the improvement	34831
the BBB score observed in OEC-transplanted animals	34850
the BBB score	34850
OEC-transplanted animals	34876
voluntary	34919
spinal reflex activity for at least four reasons	34944
spinal reflex activity	34944
at least four reasons	34971
recovery of locomotor function	35010
recovery	35010
locomotor function	35022
OEC-transplanted animals in which MEPs were restituted	35062
OEC-transplanted animals	35062
MEPs	35096
the significant correlation	35126
BBB score	35168
MEP amplitude and latency	35182
MEP amplitude	35182
latency	35200
animals with better motors skills	35223
animals	35223
better motors skills	35236
higher reconnection and faster central conduction	35272
higher reconnection	35272
faster central conduction	35296
Third	35323
significant correlations	35330
motor recovery and density of descending motor axons	35374
motor recovery and density	35374
descending motor axons	35404
the lesion	35449
animals with OEC grafts	35469
animals	35469
OEC grafts	35482
reduced hyperreflexia	35503
control-transected animals	35537
the H/M amplitude ratio	35577
The H/M amplitude ratio	35602
spinal cord section -LRB- Malmsten , 1983 ; Valero-Cabre ' et al. , 2004 -RRB-	35642
spinal cord section	35642
Malmsten , 1983 ; Valero-Cabre ' et al. , 2004	35663
Malmsten	35663
1983 ; Valero-Cabre ' et al.	35673
1983	35673
Valero-Cabre ' et al.	35679
Valero-Cabre '	35679
et al.	35693
2004	35701
the H-reflex	35715
interruption of supraspinal motor control	35751
interruption	35751
supraspinal motor control	35767
The increase in the H/M ratio	35794
The increase	35794
the H/M ratio	35810
time in DMinjected groups along the 9 months	35845
time	35845
DMinjected groups along the 9 months	35853
DMinjected groups	35853
the 9 months	35877
injury	35896
the other hand	35907
the H/M ratio	35923
2 to 3 months	35958
3 to 4 months in delayed OEC-grafted animals , the time points corresponding with MEPs recovery	35992
3 to 4 months in delayed OEC-grafted animals	35992
3 to 4 months	35992
delayed OEC-grafted animals	36009
the time points corresponding with MEPs recovery	36038
the time points	36038
MEPs recovery	36073
These results	36088
regenerated supraspinal axons in OEC-transplanted animals	36115
regenerated supraspinal axons	36115
OEC-transplanted animals	36148
the previously facilitated reflex circuits at lumbar cord segments	36182
the previously	36182
reflex circuits	36209
lumbar cord segments	36228
acute but not delayed OEC grafts	36265
acute	36265
not delayed OEC grafts	36275
a reduction	36306
the H/M ratio	36321
rats in which MEPs did not recover	36343
rats	36343
MEPs	36357
The neuroprotective effects exerted by transplanted cells at perilesional regions after acute transplantation	36379
The neuroprotective effects	36379
transplanted cells at perilesional regions after acute transplantation	36418
transplanted cells	36418
perilesional regions after acute transplantation	36440
perilesional regions	36440
acute transplantation	36467
this fact -LRB- Verdu ' et al. , 2001	36503
this fact -LRB- Verdu ' et al.	36503
this fact	36503
Verdu ' et al.	36514
Verdu '	36514
et al.	36521
2001	36529
These results	36536
return of electrophysiological and behavioral responses after OEC transplants	36563
return	36563
electrophysiological and behavioral responses after OEC transplants	36573
electrophysiological and behavioral responses	36573
OEC transplants	36625
remnant fibers following surgical transection , because motor improvement was achieved only after a extended period -LRB- 2 and 3 months following injury in OECac and OECdl groups , respectively -RRB- , longer than the reported time required for spontaneous recovery -LRB- Basso et al. , 1996 ; You et al. , 2003 -RRB-	36652
remnant fibers	36652
surgical transection , because motor improvement was achieved only after a extended period -LRB- 2 and 3 months following injury in OECac and OECdl groups , respectively -RRB- , longer than the reported time required for spontaneous recovery -LRB- Basso et al. , 1996 ; You et al. , 2003 -RRB-	36677
surgical transection	36677
motor improvement	36707
a extended period -LRB- 2 and 3 months following injury in OECac and OECdl groups , respectively -RRB-	36749
a extended period	36749
2 and 3 months following injury in OECac and OECdl groups , respectively	36768
2 and 3 months	36768
injury in OECac and OECdl groups , respectively	36793
injury in OECac and OECdl groups	36793
injury	36793
OECac and OECdl groups	36803
the reported time required for spontaneous recovery -LRB- Basso et al. , 1996 ; You et al. , 2003 -RRB-	36854
the reported time	36854
spontaneous recovery -LRB- Basso et al. , 1996 ; You et al. , 2003 -RRB-	36885
spontaneous recovery	36885
Basso	36907
et al. , 1996 ; You et al. , 2003	36913
et al.	36913
1996 ; You et al.	36921
1996	36921
You et al.	36927
You	36927
et al.	36931
2003	36939
Axonal regrowth and reconnection of descending motor fibers	36946
Axonal regrowth and reconnection	36946
descending motor fibers	36982
histological results	37023
Immunostaining against NF-200 and GAP-43	37045
Immunostaining	37045
NF-200 and GAP-43	37068
OEC-transplanted animals	37098
higher immunoreactivity	37133
the lesion epicenter	37164
DM-injected animals	37201
more axonal fibers	37238
transplanted animals	37280
DM groups , in OEC-grafted animals	37316
DM groups	37316
OEC-grafted animals	37330
more CGRP labeled sensory fibers	37351
more CGRP	37351
sensory fibers	37369
the lesion	37404
increased sprouting of ascending fibers , and also rostral to the lesion edge , suggesting that regeneration of sensory fibers occurred in transplanted rats , although we can not discard that some dorsal root afferent axons rostral to the lesion turned caudally to the lesion site	37430
increased sprouting	37430
fibers , and also rostral	37463
fibers	37463
rostral	37480
the lesion edge	37491
regeneration of sensory fibers	37524
regeneration	37524
sensory fibers	37540
transplanted rats	37567
we	37595
some dorsal root afferent axons rostral to the lesion	37618
some dorsal root afferent axons rostral	37618
the lesion	37661
the lesion site	37691
axonal regeneration and continuity across the lesion site	37722
axonal regeneration and continuity	37722
the lesion site	37764
CGRP , DhOH , and serotonin containing axons	37796
CGRP , DhOH , and serotonin	37796
axons	37833
BDA-traced corticospinal axons	37855
raphespinal , and corticospinal fibers	37913
the caudal cord stump	37959
the lumbar segments of the spinal cord , where they projected onto premotoneuronal pools and even onto ventral horn motoneurons , only in OEC transplanted rats	37996
the lumbar segments of the spinal cord	37996
the lumbar segments	37996
the spinal cord	38019
they	38042
premotoneuronal pools	38062
ventral horn motoneurons	38098
OEC transplanted rats	38132
The presence of these descending regenerated fibers	38155
The presence	38155
these descending regenerated fibers	38171
the recovery of MEPs	38221
the recovery	38221
MEPs	38237
Other descending pathways , such as rubrospinal , vestibulospinal , and reticulospinal tracts , not studied in this work ,	38243
Other descending pathways	38243
rubrospinal , vestibulospinal , and reticulospinal tracts , not studied in this work	38278
rubrospinal , vestibulospinal , and reticulospinal tracts	38278
this work	38350
recovery of motor responses	38401
recovery	38401
motor responses	38413
MEPs	38439
amplitude	38457
their onset latency	38479
time	38505
9 months	38514
they	38523
3 -- 4 times longer latency and 10 -- 20 times lower amplitude in injured and transplanted rats	38538
3	38538
4 times longer latency and 10 -- 20 times lower amplitude in injured and transplanted rats	38540
4 times longer latency and 10	38540
4 times longer latency	38540
4 times	38540
10	38567
20 times lower amplitude in injured and transplanted rats	38570
20 times lower amplitude	38570
injured and transplanted rats	38598
injured	38598
transplanted rats	38610
intact animals	38636
This limited recovery of electrophysiological responses	38652
This limited recovery	38652
electrophysiological responses	38677
the relatively low improvement of walking behavior scored in the BBB scale	38725
the relatively low improvement	38725
behavior	38767
the BBB scale	38786
Timing of OEC transplant	38801
Timing	38801
OEC transplant	38811
respect to the time interval between injury and cell grafting	38831
respect	38831
the time interval between injury and cell grafting	38842
the time interval	38842
injury and cell grafting	38868
our results	38894
acute OEC transplants	38916
better functional and histological outcomes	38950
7-day delayed transplants	38999
differences	39035
most parameters	39072
Previous works	39089
diverging results for the most suitable timing of glial cell grafting after spinal cord injury	39118
diverging results	39118
the most suitable timing of glial cell grafting after spinal cord injury	39140
the most suitable timing	39140
glial cell grafting after spinal cord injury	39168
glial cell grafting	39168
spinal cord injury	39194
Martin et al. -LRB- 1996 -RRB-	39214
Martin et al.	39214
Martin	39214
et al.	39221
1996	39229
immediate -LRB- 30 min -RRB- or 10 - day	39253
immediate -LRB- 30 min -RRB-	39253
immediate	39253
30 min	39264
10 - day	39275
10	39275
day	39279
Schwann cell grafts	39291
not intermediate -LRB- 4 days -RRB- grafts	39316
4 days	39334
the size of cavitation	39357
the size	39357
cavitation	39369
mildly injured spinal cords	39383
They	39412
release of cytotoxic metabolites	39432
release	39432
cytotoxic metabolites	39443
acute transplantation	39487
the grafted cells at an intermediate stage -LRB- Martin et al. , 1996 -RRB-	39534
the grafted cells	39534
an intermediate stage -LRB- Martin et al. , 1996 -RRB-	39555
an intermediate stage	39555
Martin	39578
et al. , 1996	39585
et al.	39585
1996	39593
the other hand	39603
immediate transplantation of OECs	39619
immediate transplantation	39619
OECs	39648
locomotor behavior	39669
moderate contusion -LRB- Plant et al. , 2003 ; Resnick et al. , 2003 -RRB-	39694
moderate contusion	39694
Plant	39714
et al. , 2003 ; Resnick et al. , 2003	39720
et al.	39720
2003 ; Resnick et al.	39728
2003	39728
Resnick et al.	39734
Resnick	39734
et al.	39742
2003	39750
7-day delayed transplantation	39764
a slight improvement	39803
that	39833
tissue preservation	39839
timings	39881
Plant et al. , 2003	39890
Plant	39890
et al.	39896
2003	39904
The present study	39911
the first to compare the regenerative effects exerted by OECs when they are transplanted acutely or 1 week delayed after spinal cord transection	39932
the regenerative effects exerted by OECs when they are transplanted acutely or 1 week delayed after spinal cord transection	39953
the regenerative effects exerted by OECs when they are transplanted acutely	39953
the regenerative effects	39953
OECs when they are transplanted acutely	39989
OECs	39989
they	39999
1 week delayed after spinal cord transection	40032
1 week	40032
spinal cord transection	40053
previous studies of complete spinal cord transection	40081
previous studies	40081
complete spinal cord transection	40101
OECs	40135
injury	40183
4 weeks	40201
most cases	40217
beneficial but limited effects	40228
axonal regeneration and recovery -LRB- Lu et al. , 2001 , 2002 ; Ramo ' n-Cueto et al. , 2000 -RRB-	40273
axonal regeneration and recovery	40273
Lu et al. , 2001 , 2002 ; Ramo ' n-Cueto et al. , 2000	40307
Lu	40307
et al. , 2001 , 2002 ; Ramo ' n-Cueto et al. , 2000	40310
et al.	40310
2001	40318
2002 ; Ramo ' n-Cueto et al.	40324
2002	40324
Ramo ' n-Cueto et al.	40330
Ramo ' n-Cueto	40330
Ramo '	40330
et al.	40343
2000	40351
the effects of glial cell grafts	40369
the effects	40369
glial cell grafts	40384
the type and severity of the spinal cord injury , the time interval between injury and grafting , the type and purity of the cultured cells for the transplant -LRB- Imaizumi et al. , 2000 -RRB- , the amount of cells , and the precise site of transplantation	40424
the type and severity of the spinal cord injury	40424
the type and severity	40424
the spinal cord injury	40449
the time interval between injury and grafting	40473
the time interval	40473
injury and grafting	40499
the type and purity of the cultured cells for the transplant -LRB- Imaizumi et al. , 2000 -RRB- , the amount of cells , and the precise site of transplantation	40520
the type and purity	40520
the cultured cells for the transplant -LRB- Imaizumi et al. , 2000 -RRB- , the amount of cells , and the precise site of transplantation	40543
the	40543
cells for the transplant -LRB- Imaizumi et al. , 2000 -RRB- , the amount of cells , and the precise site of transplantation	40556
cells for the transplant -LRB- Imaizumi et al. , 2000 -RRB-	40556
cells	40556
the transplant -LRB- Imaizumi et al. , 2000 -RRB-	40566
the transplant	40566
Imaizumi	40582
et al. , 2000	40591
et al.	40591
2000	40599
the amount of cells	40606
the amount	40606
cells	40620
the precise site of transplantation	40631
the precise site	40631
transplantation	40651
Mechanisms of OEC-induced regeneration	40668
Mechanisms	40668
OEC-induced regeneration	40682
previous studies on an incomplete spinal cord injury model	40710
previous studies	40710
an incomplete spinal cord injury model	40730
we	40770
OECs	40785
astrocyte hypertrophy and chondroitin sulphate proteoglycan expression -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Verdu ' et al. , 2001 , 2003 -RRB-	40801
astrocyte hypertrophy	40801
chondroitin sulphate proteoglycan expression -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Verdu ' et al. , 2001 , 2003 -RRB-	40827
chondroitin sulphate proteoglycan expression	40827
Garcı ' a-Alı ' as et al. , 2004 ; Verdu ' et al. , 2001 , 2003	40873
Garcı ' a-Alı ' as et al.	40873
Garcı ' a-Alı	40873
et al.	40888
2004 ; Verdu ' et al.	40896
2004	40896
Verdu ' et al.	40902
Verdu '	40902
et al.	40909
2001 , 2003	40917
2001	40917
2003	40923
spinal cord transection	40936
GFAP and NG2 immunoreactivity	40961
9 months in animals with OEC transplants	41028
9 months	41028
animals with OEC transplants	41040
animals	41040
OEC transplants	41053
those grafted acutely	41084
those	41084
Reactive astrogliosis and increased expression of NG2 , the proteoglycan with highest axonal repelling features ,	41107
Reactive astrogliosis	41107
increased expression	41133
NG2 , the proteoglycan with highest axonal repelling features ,	41157
NG2	41157
the proteoglycan with highest axonal repelling features	41162
the proteoglycan	41162
highest axonal repelling features	41184
the failure of axonal regeneration in the central nervous system -LRB- Fawcett and Asher , 1999 -RRB-	41233
the failure	41233
axonal regeneration in the central nervous system -LRB- Fawcett and Asher , 1999 -RRB-	41248
axonal regeneration	41248
the central nervous system -LRB- Fawcett and Asher , 1999 -RRB-	41271
the central nervous system	41271
Fawcett and Asher	41299
1999	41318
GFAP and NG2 expressions	41325
the first week after spinal cord injury	41366
the first week	41366
spinal cord injury	41387
high levels for at least 1 year -LRB- Camand et al. , 2004 ; Tang et al. , 2003 -RRB-	41420
high levels	41420
at least 1 year -LRB- Camand et al. , 2004 ; Tang et al. , 2003 -RRB-	41436
at least 1 year	41436
Camand	41453
et al. , 2004 ; Tang et al. , 2003	41460
et al.	41460
2004 ; Tang et al.	41468
2004	41468
Tang et al.	41474
Tang	41474
et al.	41479
2003	41487
cell grafting	41505
1 week	41519
injury	41536
astrocyte reactivity and related expression of inhibitory molecules	41573
astrocyte reactivity and related expression	41573
inhibitory molecules	41620
The higher regeneration observed following acute than delayed OEC grafts in our rats	41642
The higher regeneration	41642
delayed OEC grafts in our rats	41696
delayed OEC grafts	41696
our rats	41718
part	41758
a more effective downregulation of these inhibitory factors	41767
a more effective downregulation	41767
these inhibitory factors	41802
OECs	41828
several growth factors that promote the survival and regeneration of different types of neurons -LRB- Woodhall et al. , 2001 ; Lipson et al. , 2003 -RRB-	41861
several growth factors	41861
the survival and regeneration of different types of neurons -LRB- Woodhall et al. , 2001 ; Lipson et al. , 2003 -RRB-	41897
the survival and regeneration	41897
different types of neurons -LRB- Woodhall et al. , 2001 ; Lipson et al. , 2003 -RRB-	41930
different types	41930
neurons -LRB- Woodhall et al. , 2001 ; Lipson et al. , 2003 -RRB-	41949
neurons	41949
Woodhall	41958
et al. , 2001 ; Lipson et al. , 2003	41967
et al.	41967
2001 ; Lipson et al.	41975
2001	41975
Lipson et al.	41981
Lipson	41981
et al.	41988
2003	41996
The capabilities of OECs to promote and guide axonal regeneration	42003
The capabilities	42003
OECs to promote and guide axonal regeneration	42023
axonal regeneration	42049
several regions of the central nervous system	42095
several regions	42095
the central nervous system	42114
Transplants of cultured OECs guided the reentry of regenerating dorsal root axons into the dorsal horn and the synapses formed by regenerating sensory fibers	42142
Transplants	42142
OECs	42166
the reentry of regenerating dorsal root axons into the dorsal horn	42178
the reentry	42178
dorsal root axons	42206
the dorsal horn	42229
the synapses	42249
sensory fibers	42285
functional restitution of spinal reflex arcs -LRB- Navarro et al. , 1999 -RRB-	42308
functional restitution	42308
spinal reflex arcs -LRB- Navarro et al. , 1999 -RRB-	42334
spinal reflex arcs	42334
Navarro	42354
et al. , 1999	42362
et al.	42362
1999	42370
the corticospinal tract	42382
OECs transplanted into the lesion site	42428
OECs	42428
the lesion site	42451
the elongation of corticospinal axons -LRB- Li et al. , 1998 -RRB-	42471
the elongation	42471
corticospinal axons -LRB- Li et al. , 1998 -RRB-	42489
corticospinal axons	42489
Li	42510
et al. , 1998	42513
et al.	42513
1998	42521
OECs	42528
relatively long distances	42558
the spinal cord	42605
the injured tissue -LRB- Boruch et al. , 2001 -RRB-	42636
the injured tissue	42636
Boruch	42656
et al. , 2001	42663
et al.	42663
2001	42671
the absence of a specific marker to label OECs	42685
the absence	42685
a specific marker to label OECs	42700
OECs	42727
we	42733
transplanted cells	42766
the spinal cord parenchyma	42814
9.5 months postinjury	42844
previous studies -LRB- Navarro et al. , 1999 ; Verdu ' et al. , 2001 -RRB-	42870
previous studies	42870
Navarro	42888
et al. , 1999 ; Verdu ' et al. , 2001	42896
et al.	42896
1999 ; Verdu ' et al.	42904
1999	42904
Verdu ' et al.	42910
Verdu '	42910
et al.	42917
2001	42925
we	42932
OECs pre-labeled with PKH26	42943
OECs	42943
PKH26	42965
the capabilities of those cells	42983
the capabilities	42983
those cells	43003
the injured spinal cord tissue	43041
the present study	43085
we	43104
transplanted cells	43121
it	43148
compounds	43183
the viability and phenotypic expression of cell markers , such as p75NTR ,	43200
the viability and phenotypic expression	43200
cell markers , such as p75NTR ,	43243
cell markers	43243
p75NTR	43265
glial cells -LRB- Mosahebi et al. , 2000 -RRB-	43276
glial cells	43276
Mosahebi	43289
et al. , 2000	43298
et al.	43298
2000	43306
they	43317
OECs	43335
other cells -LRB- Andrews and Stelzner , 2004 -RRB-	43343
other cells	43343
Andrews and Stelzner	43356
2004	43378
it	43395
chemical labeling distinctly	43415
chemical	43415
the 9-month-long follow-up in the grafted cells	43457
the 9-month-long follow-up	43457
the grafted cells	43487
OECs expressing a gene reporter -LRB- Cao et al. , 2004 ; Ramer et al. , 2004a ; Ruitenberg et al. , 2003 -RRB- and by using immunostaining for p75NTR -LRB- Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. , 2003 ; Resnick et al. , 2003 ; Ruitenberg et al. , 2003 ; Takami et al. , 2002 -RRB-	43523
OECs expressing a gene reporter -LRB- Cao et al. , 2004 ; Ramer et al. , 2004a ; Ruitenberg et al. , 2003 -RRB- and by using immunostaining for p75NTR	43523
OECs	43523
a gene reporter -LRB- Cao et al. , 2004 ; Ramer et al. , 2004a ; Ruitenberg et al. , 2003 -RRB-	43539
a gene reporter	43539
Cao et al. , 2004 ; Ramer et al. , 2004a ; Ruitenberg et al. , 2003	43556
Cao	43556
et al. , 2004 ; Ramer et al. , 2004a ; Ruitenberg et al. , 2003	43560
et al. , 2004	43560
et al.	43560
2004	43568
Ramer et al. , 2004a	43574
Ramer	43574
et al. , 2004a	43580
et al.	43580
2004a	43588
Ruitenberg et al. , 2003	43595
Ruitenberg	43595
et al. , 2003	43606
et al.	43606
2003	43614
immunostaining	43633
p75NTR	43652
Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. , 2003 ; Resnick et al. , 2003 ; Ruitenberg et al. , 2003 ; Takami et al. , 2002	43660
Garcı ' a-Alı ' as et al. , 2004 ; Plant et al. , 2003 ; Resnick et al. , 2003 ; Ruitenberg et al. , 2003 ; Takami et al. ,	43660
Garcı ' a-Alı ' as et al. , 2004	43660
Garcı ' a-Alı	43660
et al.	43675
2004	43683
Plant et al. , 2003	43689
Plant	43689
et al. , 2003	43695
et al.	43695
2003	43703
Resnick et al. , 2003	43709
Resnick	43709
et al. , 2003	43717
et al.	43717
2003	43725
Ruitenberg et al. , 2003 ; Takami et al. ,	43731
Ruitenberg	43731
et al. , 2003 ; Takami et al. ,	43742
et al.	43742
2003 ; Takami et al.	43750
2003	43750
Takami et al.	43756
Takami	43756
et al.	43763
2002	43771
it	43778
OECs	43808
the spinal cord for at least 4 months after implantation	43836
the spinal cord	43836
at least 4 months after implantation	43856
at least 4 months	43856
implantation	43880
the present work	43897
we	43915
p75NTR-positive cells	43934
the spinal cord sections 9 months	43963
the spinal cord sections	43963
9 months	43988
injury	44003
Rubio et al. -LRB- 2002 -RRB-	44011
Rubio et al.	44011
Rubio	44011
et al.	44017
2002	44025
OECs	44045
p75 receptor	44065
time	44083
the lack of p75NTR-immunoreactive cells within the spinal cord parenchyma	44109
the lack	44109
p75NTR-immunoreactive cells within the spinal cord parenchyma	44121
p75NTR-immunoreactive cells	44121
the spinal cord parenchyma	44156
the death of the transplanted cells	44210
the death	44210
the transplanted cells	44223
the 9 months	44253
the fate of the transplanted cells over such a long time	44276
the fate	44276
the transplanted cells over such a long time	44288
the transplanted cells	44288
such a long time	44316
further investigation	44339
conclusion	44365
this work	44377
acute and delayed purified OEC grafts	44405
acute	44405
delayed purified OEC grafts	44415
regeneration and partial functional recovery after complete spinal cord transection	44451
regeneration and partial functional recovery	44451
complete spinal cord transection	44502
acute transplantation of OECs	44551
acute transplantation	44551
OECs	44576
slightly better results	44590
1 week delayed transplantation	44619
1 week	44619
transplantation	44634
This	44651
a more suitable environment for axonal regeneration	44675
a more suitable environment	44675
axonal regeneration	44707
delayed grafting	44744
This study	44762
new insight	44782
the concept	44799
OECs	44816
a promising approach	44832
spinal cord injuries	44863
transplantation	44893
lesion	44934
